Details of the Drug Combination

General Information of Drug Combination (ID: DCNMO43)

• Drug Combination Name: Daunorubicin + Cytarabine
• Indication: Acute Myeloid Leukemia; Status: Phase 1 [1]
• Component Drugs:
  Daunorubicin (DMQUSBT): Small molecular drug
  Cytarabine (DMZD5QR): Small molecular drug

Molecular Interaction Atlas of This Drug Combination

Indication(s) of Daunorubicin

Disease Entry	ICD 11	Status	REF
Acute monocytic leukemia	N.A.	Approved	[2]
Acute myelogenous leukaemia	2A41	Approved	[2]
Acute myeloid leukaemia	2A60	Approved	[3]
Kaposi sarcoma	2B57	Approved	[4]
Leukemia	N.A.	Approved	[2]
Solid tumour/cancer	2A00-2F9Z	Phase 2	[5]

Daunorubicin Interacts with 2 DTT Molecule(s)

DTT Name	DTT ID	UniProt ID	Mode of Action	REF
DNA replication (DNA repli)	TTABD5E	NOUNIPROTAC	Modulator	[14]
Human Deoxyribonucleic acid (hDNA)	TTUTN1I	NOUNIPROTAC	Intercalator	[15]

Daunorubicin Interacts with 4 DTP Molecule(s)

DTP Name	DTP ID	UniProt ID	Mode of Action	REF
Multidrug resistance-associated protein 1 (ABCC1)	DTSYQGK	MRP1_HUMAN	Substrate	[16]
P-glycoprotein 1 (ABCB1)	DTUGYRD	MDR1_HUMAN	Substrate	[17]
Breast cancer resistance protein (ABCG2)	DTI7UX6	ABCG2_HUMAN	Substrate	[18]
Multidrug resistance-associated protein 6 (ABCC6)	DT582KR	MRP6_HUMAN	Substrate	[19]

Daunorubicin Interacts with 6 DME Molecule(s)

DME Name	DME ID	UniProt ID	Mode of Action	REF
Cytochrome P450 3A4 (CYP3A4)	DE4LYSA	CP3A4_HUMAN	Metabolism	[20]
Cytochrome P450 1A2 (CYP1A2)	DEJGDUW	CP1A2_HUMAN	Metabolism	[20]
Cytochrome P450 1A1 (CYP1A1)	DE6OQ3W	CP1A1_HUMAN	Metabolism	[20]
NADPH-dependent carbonyl reductase 1 (CBR1)	DE9JFMC	CBR1_HUMAN	Metabolism	[21]
NADPH-dependent carbonyl reductase 3 (CBR3)	DEIVKZ8	CBR3_HUMAN	Metabolism	[22]
NADPH-cytochrome P450 reductase (CPR)	DE3N2FM	NCPR_HUMAN	Metabolism	[23]

Daunorubicin Interacts with 158 DOT Molecule(s)

DOT Name	DOT ID	UniProt ID	Mode of Action	REF
Carbonyl reductase 3 (CBR3)	OT9G6SF0	CBR3_HUMAN	Affects Response To Substance	[22]
Broad substrate specificity ATP-binding cassette transporter ABCG2 (ABCG2)	OTW8V2V1	ABCG2_HUMAN	Increases Expression	[24]
ATP-dependent translocase ABCB1 (ABCB1)	OTEJROBO	MDR1_HUMAN	Decreases Expression	[25]
Multidrug resistance-associated protein 1 (ABCC1)	OTGUN89S	MRP1_HUMAN	Decreases Response To Substance	[26]
Heterogeneous nuclear ribonucleoprotein D0 (HNRNPD)	OT5UO1FA	HNRPD_HUMAN	Affects Response To Substance	[27]
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)	OT5VYOSM	IKKE_HUMAN	Affects Response To Substance	[27]
Cytochrome P450 1B1 (CYP1B1)	OTYXFLSD	CP1B1_HUMAN	Affects Response To Substance	[27]
SEC14-like protein 3 (SEC14L3)	OTGQ8GWM	S14L3_HUMAN	Increases ADR	[27]
Retinoic acid receptor gamma (RARG)	OT8LHMDH	RARG_HUMAN	Increases Response To Substance	[28]
NAD(P)H dehydrogenase 1 (NQO1)	OTZGGIVK	NQO1_HUMAN	Decreases Expression	[29]
Voltage-dependent T-type calcium channel subunit alpha-1G (CACNA1G)	OTGKBRE4	CAC1G_HUMAN	Decreases Expression	[8]
Tyrosine-protein kinase JAK2 (JAK2)	OTBIDOOR	JAK2_HUMAN	Decreases Expression	[8]
Sodium channel subunit beta-2 (SCN2B)	OTFAHJ38	SCN2B_HUMAN	Decreases Expression	[8]
LIM domain-binding protein 3 (LDB3)	OTGQL1AM	LDB3_HUMAN	Decreases Expression	[8]
Creatine kinase M-type (CKM)	OTME0KO7	KCRM_HUMAN	Decreases Expression	[8]
Glutathione peroxidase 1 (GPX1)	OTE2O72Q	GPX1_HUMAN	Increases Expression	[8]
Glycogen phosphorylase, muscle form (PYGM)	OTWLVWTV	PYGM_HUMAN	Decreases Expression	[8]
Dystrophin (DMD)	OTD21T5J	DMD_HUMAN	Decreases Expression	[8]
Myosin-7 (MYH7)	OT4Z9T8N	MYH7_HUMAN	Decreases Expression	[8]
Myosin-6 (MYH6)	OT3YNCH1	MYH6_HUMAN	Decreases Expression	[8]
Troponin T, slow skeletal muscle (TNNT1)	OT8PBOAR	TNNT1_HUMAN	Decreases Expression	[8]
Receptor tyrosine-protein kinase erbB-3 (ERBB3)	OTRSST0A	ERBB3_HUMAN	Decreases Expression	[8]
Sarcoplasmic reticulum histidine-rich calcium-binding protein (HRC)	OTDLEJ4T	SRCH_HUMAN	Decreases Expression	[8]
Tumor necrosis factor receptor superfamily member 6 (FAS)	OTP9XG86	TNR6_HUMAN	Increases Expression	[8]
Sodium/potassium-transporting ATPase subunit alpha-2 (ATP1A2)	OTCF8OWW	AT1A2_HUMAN	Decreases Expression	[8]
Potassium voltage-gated channel subfamily KQT member 1 (KCNQ1)	OT8SPJNX	KCNQ1_HUMAN	Decreases Expression	[8]
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)	OTDAC6Z0	PRKX_HUMAN	Increases Expression	[8]
Myomesin-2 (MYOM2)	OTD2UOXW	MYOM2_HUMAN	Decreases Expression	[8]
Inward rectifier potassium channel 2 (KCNJ2)	OT2OQEZS	KCNJ2_HUMAN	Increases Expression	[8]
Actin, alpha skeletal muscle (ACTA1)	OTOVGLPG	ACTS_HUMAN	Decreases Expression	[8]
Iroquois-class homeodomain protein IRX-4 (IRX4)	OT0TV6WK	IRX4_HUMAN	Decreases Expression	[8]
Ankyrin-2 (ANK2)	OTWB4R1Y	ANK2_HUMAN	Decreases Expression	[8]
Apoptosis regulator BAX (BAX)	OTAW0V4V	BAX_HUMAN	Increases Expression	[8]
Potassium voltage-gated channel subfamily H member 2 (KCNH2)	OTZX881H	KCNH2_HUMAN	Decreases Expression	[8]
Dual specificity protein phosphatase 4 (DUSP4)	OT6WAO12	DUS4_HUMAN	Increases Expression	[8]
Sodium channel protein type 5 subunit alpha (SCN5A)	OTGYZWR6	SCN5A_HUMAN	Decreases Expression	[8]
Protein phosphatase 1 regulatory subunit 3A (PPP1R3A)	OTJL9VYP	PPR3A_HUMAN	Decreases Expression	[8]
Caveolae-associated protein 4 (CAVIN4)	OTB1DM2C	CAVN4_HUMAN	Decreases Expression	[8]
Nebulin-related-anchoring protein (NRAP)	OTO6H3YF	NRAP_HUMAN	Decreases Expression	[8]
Ryanodine receptor 2 (RYR2)	OT0PF19E	RYR2_HUMAN	Decreases Expression	[8]
Growth/differentiation factor 15 (GDF15)	OTWQN50N	GDF15_HUMAN	Increases Expression	[8]
Histone-lysine N-methyltransferase PRDM16 (PRDM16)	OT0BGA27	PRD16_HUMAN	Decreases Expression	[8]
Voltage-dependent calcium channel subunit alpha-2/delta-2 (CACNA2D2)	OTFJXVQQ	CA2D2_HUMAN	Decreases Expression	[8]
Atrial natriuretic peptide-converting enzyme (CORIN)	OT4SK7DK	CORIN_HUMAN	Decreases Expression	[8]
DNA fragmentation factor subunit alpha (DFFA)	OTFPFMT8	DFFA_HUMAN	Increases Degradation	[30]
Agrin (AGRN)	OTWJENAZ	AGRIN_HUMAN	Increases Expression	[31]
Etoposide-induced protein 2.4 homolog (EI24)	OTD4NOYS	EI24_HUMAN	Increases Expression	[31]
Tax1-binding protein 3 (TAX1BP3)	OTQ6IB4T	TX1B3_HUMAN	Increases Expression	[31]
Aurora kinase A (AURKA)	OTMX0HYT	AURKA_HUMAN	Decreases Expression	[32]
Protein Mdm4 (MDM4)	OTU10BSF	MDM4_HUMAN	Decreases Expression	[33]
Baculoviral IAP repeat-containing protein 5 (BIRC5)	OTILXZYL	BIRC5_HUMAN	Increases Expression	[34]
Cytoplasmic protein NCK2 (NCK2)	OTUYPF55	NCK2_HUMAN	Decreases Expression	[31]
Protein regulator of cytokinesis 1 (PRC1)	OTHD0XS0	PRC1_HUMAN	Decreases Expression	[31]
GTPase NRas (NRAS)	OTVQ1DG3	RASN_HUMAN	Increases Expression	[33]
Estrogen receptor (ESR1)	OTKLU61J	ESR1_HUMAN	Decreases Activity	[9]
Glucocorticoid receptor (NR3C1)	OTCI2YDI	GCR_HUMAN	Decreases Activity	[35]
Cellular tumor antigen p53 (TP53)	OTIE1VH3	P53_HUMAN	Increases Expression	[33]
Plasminogen activator inhibitor 1 (SERPINE1)	OTT0MPQ3	PAI1_HUMAN	Decreases Expression	[36]
Endothelin-1 (EDN1)	OTZCACEG	EDN1_HUMAN	Decreases Expression	[37]
Retinoblastoma-associated protein (RB1)	OTQJUJMZ	RB_HUMAN	Increases Expression	[33]
Annexin A2 (ANXA2)	OTFNS0CC	ANXA2_HUMAN	Decreases Expression	[38]
Transcription factor Sp1 (SP1)	OTISPT4X	SP1_HUMAN	Decreases Expression	[39]
Interleukin-6 receptor subunit alpha (IL6R)	OTCQL07Z	IL6RA_HUMAN	Decreases Expression	[10]
Annexin A4 (ANXA4)	OTUCRYXL	ANXA4_HUMAN	Increases Expression	[31]
Poly polymerase 1 (PARP1)	OT310QSG	PARP1_HUMAN	Increases Cleavage	[40]
Interleukin-8 (CXCL8)	OTS7T5VH	IL8_HUMAN	Decreases Expression	[10]
Androgen receptor (AR)	OTUBKAZZ	ANDR_HUMAN	Decreases Activity	[9]
Apoptosis regulator Bcl-2 (BCL2)	OT9DVHC0	BCL2_HUMAN	Decreases Expression	[41]
Microtubule-associated protein tau (MAPT)	OTMTP2Z7	TAU_HUMAN	Decreases Expression	[42]
C-C motif chemokine 4 (CCL4)	OT6B8P25	CCL4_HUMAN	Decreases Expression	[10]
C-C motif chemokine 2 (CCL2)	OTAD2HEL	CCL2_HUMAN	Decreases Expression	[10]
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1)	OTPWI88U	CEAM1_HUMAN	Increases Expression	[31]
Tissue factor (F3)	OT3MSU3B	TF_HUMAN	Increases Expression	[43]
Histone H2AX (H2AX)	OT18UX57	H2AX_HUMAN	Increases Expression	[39]
Cyclic AMP-responsive element-binding protein 1 (CREB1)	OT1MDLA1	CREB1_HUMAN	Decreases Phosphorylation	[39]
Natriuretic peptides B (NPPB)	OTSN2IPY	ANFB_HUMAN	Increases Expression	[44]
Sphingomyelin phosphodiesterase (SMPD1)	OTZSMA54	ASM_HUMAN	Increases Expression	[45]
Syndecan-1 (SDC1)	OTWKRVZC	SDC1_HUMAN	Increases Expression	[31]
NADPH:adrenodoxin oxidoreductase, mitochondrial (FDXR)	OTPDCK1F	ADRO_HUMAN	Increases Expression	[31]
Ribosomal protein S6 kinase beta-1 (RPS6KB1)	OTAELNGX	KS6B1_HUMAN	Increases Phosphorylation	[46]
G1/S-specific cyclin-E1 (CCNE1)	OTLD7UID	CCNE1_HUMAN	Affects Expression	[33]
Mitogen-activated protein kinase 3 (MAPK3)	OTCYKGKO	MK03_HUMAN	Decreases Phosphorylation	[39]
Mitogen-activated protein kinase 1 (MAPK1)	OTH85PI5	MK01_HUMAN	Decreases Phosphorylation	[39]
G1/S-specific cyclin-D3 (CCND3)	OTNKPQ22	CCND3_HUMAN	Increases Expression	[33]
M-phase inducer phosphatase 1 (CDC25A)	OTSLKKCO	MPIP1_HUMAN	Increases Expression	[33]
Peroxisome proliferator-activated receptor gamma (PPARG)	OTHMARHO	PPARG_HUMAN	Decreases Activity	[9]
Cyclin-dependent kinase inhibitor 1 (CDKN1A)	OTQWHCZE	CDN1A_HUMAN	Increases Expression	[33]
Tumor necrosis factor ligand superfamily member 9 (TNFSF9)	OTV9L89D	TNFL9_HUMAN	Increases Expression	[31]
Serine/threonine-protein kinase mTOR (MTOR)	OTHH8KU7	MTOR_HUMAN	Increases Phosphorylation	[46]
Caspase-3 (CASP3)	OTIJRBE7	CASP3_HUMAN	Increases Activity	[40]
Cyclin-dependent kinase inhibitor 2A (CDKN2A)	OTN0ZWAE	CDN2A_HUMAN	Affects Expression	[33]
Cyclin-dependent kinase 4 inhibitor B (CDKN2B)	OTAG24N1	CDN2B_HUMAN	Increases Expression	[33]
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)	OTI2OREX	MP2K3_HUMAN	Increases Expression	[31]
Dual specificity protein kinase CLK2 (CLK2)	OT1CRSY2	CLK2_HUMAN	Increases Expression	[33]
Caspase-9 (CASP9)	OTD4RFFG	CASP9_HUMAN	Increases Cleavage	[39]
Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PPP2CA)	OT83PT85	PP2AA_HUMAN	Increases Expression	[39]
Cytochrome c (CYCS)	OTBFALJD	CYC_HUMAN	Affects Expression	[34]
Transcription factor Sp3 (SP3)	OTYDQZ1T	SP3_HUMAN	Increases Expression	[45]
Peroxisome proliferator-activated receptor delta (PPARD)	OTI4WTOP	PPARD_HUMAN	Decreases Activity	[9]
Antigen peptide transporter 1 (TAP1)	OTJL27PW	TAP1_HUMAN	Increases Expression	[31]
CCAAT/enhancer-binding protein zeta (CEBPZ)	OT11BATG	CEBPZ_HUMAN	Decreases Expression	[31]
Protein kinase C delta type (PRKCD)	OTSEH90E	KPCD_HUMAN	Increases Cleavage	[47]
Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1)	OT2YYI1A	MCL1_HUMAN	Decreases Expression	[39]
Serine-protein kinase ATM (ATM)	OTQVOHLT	ATM_HUMAN	Increases Expression	[33]
Eukaryotic translation initiation factor 4E-binding protein 1 (EIF4EBP1)	OTHBQVD5	4EBP1_HUMAN	Increases Phosphorylation	[46]
Retinoblastoma-binding protein 5 (RBBP5)	OT12W2MK	RBBP5_HUMAN	Affects Expression	[33]
Transcription factor E2F5 (E2F5)	OT1XWING	E2F5_HUMAN	Increases Expression	[33]
Cyclin-G2 (CCNG2)	OTII38K2	CCNG2_HUMAN	Increases Expression	[48]
Quinone oxidoreductase PIG3 (TP53I3)	OTSCM68G	QORX_HUMAN	Increases Expression	[31]
EPM2A-interacting protein 1 (EPM2AIP1)	OT21ALNF	EPMIP_HUMAN	Increases Expression	[31]
E3 ubiquitin-protein ligase RBBP6 (RBBP6)	OTTVG4HU	RBBP6_HUMAN	Increases Expression	[33]
Bile acid receptor (NR1H4)	OTWZLPTB	NR1H4_HUMAN	Decreases Activity	[9]
Mitogen-activated protein kinase kinase kinase 5 (MAP3K5)	OTQR6ENW	M3K5_HUMAN	Decreases Expression	[31]
BRCA1-associated RING domain protein 1 (BARD1)	OTTC0Z9Y	BARD1_HUMAN	Affects Expression	[33]
Serine/threonine-protein kinase PLK3 (PLK3)	OT19CT2Z	PLK3_HUMAN	Increases Expression	[31]
NADPH oxidase 4 (NOX4)	OTTYQ097	NOX4_HUMAN	Increases Expression	[39]
Sphingomyelin phosphodiesterase 3 (SMPD3)	OTHQBETH	NSMA2_HUMAN	Increases Expression	[45]
F-box/WD repeat-containing protein 1A (BTRC)	OT2EZDGR	FBW1A_HUMAN	Increases Expression	[39]
Calcium-binding protein 39 (CAB39)	OT2CL9ST	CAB39_HUMAN	Decreases Expression	[31]
Tyrosine-protein kinase ABL1 (ABL1)	OT09YVXH	ABL1_HUMAN	Decreases Response To Substance	[49]
Integrin-linked kinase-associated serine/threonine phosphatase 2C (ILKAP)	OT2A6FSA	ILKAP_HUMAN	Affects Response To Substance	[12]
Kinesin-like protein KIF1A (KIF1A)	OT3JVEGV	KIF1A_HUMAN	Affects Response To Substance	[12]
Phosphatidylinositol 3-kinase regulatory subunit alpha (PIK3R1)	OT5BZ1J9	P85A_HUMAN	Affects Response To Substance	[12]
Solute carrier family 28 member 3 (SLC28A3)	OT5TLTYU	S28A3_HUMAN	Increases ADR	[11]
Protein GAPT (GAPT)	OT6C2WXX	GAPT_HUMAN	Affects Response To Substance	[12]
RAC-alpha serine/threonine-protein kinase (AKT1)	OT8H2YY7	AKT1_HUMAN	Decreases Response To Substance	[50]
Glypican-5 (GPC5)	OT8NR7GC	GPC5_HUMAN	Affects Response To Substance	[12]
Voltage-dependent L-type calcium channel subunit alpha-1S (CACNA1S)	OT96MCM2	CAC1S_HUMAN	Affects Response To Substance	[12]
Ephexin-1 (NGEF)	OT9QUXJ3	NGEF_HUMAN	Affects Response To Substance	[12]
Spliceosome-associated protein CWC27 homolog (CWC27)	OTB0HBP1	CWC27_HUMAN	Affects Response To Substance	[12]
Cadherin-13 (CDH13)	OTD2CYM5	CAD13_HUMAN	Affects Response To Substance	[12]
Sp110 nuclear body protein (SP110)	OTFW6WH7	SP110_HUMAN	Affects Response To Substance	[12]
Leucine zipper protein 2 (LUZP2)	OTGGOSPW	LUZP2_HUMAN	Affects Response To Substance	[12]
Catalase (CAT)	OTHEBX9R	CATA_HUMAN	Affects Response To Substance	[51]
Transgelin-3 (TAGLN3)	OTJBP3VJ	TAGL3_HUMAN	Affects Response To Substance	[12]
ATP-binding cassette sub-family C member 2 (ABCC2)	OTJSIGV5	MRP2_HUMAN	Affects Response To Substance	[27]
Inositol polyphosphate 4-phosphatase type II (INPP4B)	OTLROA7G	INP4B_HUMAN	Affects Response To Substance	[12]
Anoctamin-3 (ANO3)	OTM34U6Q	ANO3_HUMAN	Affects Response To Substance	[12]
Protein kinase C zeta type (PRKCZ)	OTN2FE42	KPCZ_HUMAN	Decreases Response To Substance	[52]
RelA-associated inhibitor (PPP1R13L)	OTNCPLWE	IASPP_HUMAN	Decreases Response To Substance	[53]
Transmembrane 4 L6 family member 20 (TM4SF20)	OTNXU9QW	T4S20_HUMAN	Affects Response To Substance	[12]
Aldo-keto reductase family 1 member B10 (AKR1B10)	OTOA4HTH	AK1BA_HUMAN	Decreases Response To Substance	[54]
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (PTEN)	OTOWDUNT	PTEN_HUMAN	Increases Response To Substance	[55]
Ran-binding protein 17 (RANBP17)	OTQEVTYH	RBP17_HUMAN	Affects Response To Substance	[12]
NPC intracellular cholesterol transporter 1 (NPC1)	OTRIPICX	NPC1_HUMAN	Increases Secretion	[56]
Aldo-keto reductase family 1 member B1 (AKR1B1)	OTRX72TH	ALDR_HUMAN	Increases Reduction	[57]
COX assembly mitochondrial protein 2 homolog (CMC2)	OTRYIO1J	COXM2_HUMAN	Affects Response To Substance	[12]
Glutathione S-transferase Mu 1 (GSTM1)	OTSBF2MO	GSTM1_HUMAN	Affects Response To Substance	[13]
Protein SPMIP2 (SPMIP2)	OTSNYR9R	SMIP2_HUMAN	Affects Response To Substance	[12]
Aldo-keto reductase family 1 member C3 (AKR1C3)	OTU2SXBA	AK1C3_HUMAN	Decreases Response To Substance	[58]
Slit homolog 3 protein (SLIT3)	OTU8MKEU	SLIT3_HUMAN	Affects Response To Substance	[12]
Microtubule-associated protein 1B (MAP1B)	OTVXW089	MAP1B_HUMAN	Affects Response To Substance	[12]
Antigen peptide transporter 2 (TAP2)	OTWSYFI7	TAP2_HUMAN	Affects Response To Substance	[27]
Citramalyl-CoA lyase, mitochondrial (CLYBL)	OTXZLTST	CLYBL_HUMAN	Affects Response To Substance	[12]
Limbic system-associated membrane protein (LSAMP)	OTYXVQX2	LSAMP_HUMAN	Affects Response To Substance	[12]
C-Maf-inducing protein (CMIP)	OTZN8Z4A	CMIP_HUMAN	Affects Response To Substance	[12]
Aldo-keto reductase family 1 member A1 (AKR1A1)	OTZT9NOW	AK1A1_HUMAN	Increases Reduction	[59]
EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1)	OTZVUOOB	FBLN3_HUMAN	Affects Response To Substance	[60]

Indication(s) of Cytarabine

Disease Entry	ICD 11	Status	REF
Acute lymphoblastic leukaemia	2A85	Approved	[6]
Acute myelogenous leukaemia	2A41	Approved	[7]
Adult acute monocytic leukemia	N.A.	Approved	[7]
Childhood acute megakaryoblastic leukemia	N.A.	Approved	[7]
Plasma cell myeloma	2A83.1	Approved	[7]
Neoplastic meningitis	N.A.	Investigative	[7]

Cytarabine Interacts with 1 DTT Molecule(s)

DTT Name	DTT ID	UniProt ID	Mode of Action	REF
Herpes simplex virus DNA polymerase UL30 (HSV UL30)	TTIU7X1	DPOL_HHV11	Inhibitor	[66]

Cytarabine Interacts with 6 DTP Molecule(s)

DTP Name	DTP ID	UniProt ID	Mode of Action	REF
P-glycoprotein 1 (ABCB1)	DTUGYRD	MDR1_HUMAN	Substrate	[17]
Organic cation transporter 1 (SLC22A1)	DTT79CX	S22A1_HUMAN	Substrate	[67]
Organic cation/carnitine transporter 1 (SLC22A4)	DT2EG60	S22A4_HUMAN	Substrate	[68]
Concentrative nucleoside transporter 1 (SLC28A1)	DT0EQPW	S28A1_HUMAN	Substrate	[69]
Equilibrative nucleoside transporter 1 (SLC29A1)	DTXD1TQ	S29A1_HUMAN	Substrate	[69]
Equilibrative nucleoside transporter 2 (SLC29A2)	DTW78DQ	S29A2_HUMAN	Substrate	[69]

Cytarabine Interacts with 5 DME Molecule(s)

DME Name	DME ID	UniProt ID	Mode of Action	REF
Cytochrome P450 3A4 (CYP3A4)	DE4LYSA	CP3A4_HUMAN	Metabolism	[70]
Cytidine aminohydrolase (CDA)	DEKEDRC	CDD_HUMAN	Metabolism	[71]
Ecto-5'-nucleotidase (NT5E)	DE3Z9HM	5NTD_HUMAN	Metabolism	[71]
Deoxycytidylate deaminase (DCTD)	DEXL3P2	DCTD_HUMAN	Metabolism	[71]
Cytidine deaminase (cdd)	DEYILK4	E0TLJ6_MYCHH	Metabolism	[72]

Cytarabine Interacts with 549 DOT Molecule(s)

DOT Name	DOT ID	UniProt ID	Mode of Action	REF
ATP-dependent translocase ABCB1 (ABCB1)	OTEJROBO	MDR1_HUMAN	Increases Expression	[73]
Equilibrative nucleoside transporter 1 (SLC29A1)	OTLOOZZS	S29A1_HUMAN	Decreases Response To Substance	[74]
GTP-binding protein 1 (GTPBP1)	OTA9KV6C	GTPB1_HUMAN	Increases Expression	[61]
Kinetochore protein NDC80 homolog (NDC80)	OTS7D306	NDC80_HUMAN	Increases Expression	[61]
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (PDE6D)	OTIFVXWD	PDE6D_HUMAN	Decreases Expression	[61]
Lymphocyte antigen 75 (LY75)	OTDHBU0N	LY75_HUMAN	Increases Expression	[61]
ATP-dependent DNA helicase Q5 (RECQL5)	OTVZMP1Q	RECQ5_HUMAN	Decreases Expression	[61]
SLIT and NTRK-like protein 5 (SLITRK5)	OTTSUSB8	SLIK5_HUMAN	Decreases Expression	[61]
Dihydrofolate reductase (DHFR)	OT3DVIGM	DYR_HUMAN	Increases Expression	[61]
Alpha-1-antitrypsin (SERPINA1)	OTACYW9J	A1AT_HUMAN	Increases Expression	[61]
T-cell surface glycoprotein CD8 alpha chain (CD8A)	OTDWQJXK	CD8A_HUMAN	Increases Expression	[61]
Thy-1 membrane glycoprotein (THY1)	OTVONVTB	THY1_HUMAN	Decreases Expression	[61]
Serglycin (SRGN)	OTFAVSX0	SRGN_HUMAN	Increases Expression	[61]
Non-secretory ribonuclease (RNASE2)	OT8Z4FNE	RNAS2_HUMAN	Increases Expression	[61]
Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A)	OT0OUDUT	FCG2A_HUMAN	Increases Expression	[61]
Heat shock 70 kDa protein 6 (HSPA6)	OTH4S7WB	HSP76_HUMAN	Increases Expression	[61]
Transcription factor E3 (TFE3)	OTM99ZWH	TFE3_HUMAN	Increases Expression	[61]
Protein S100-P (S100P)	OTJCXNJG	S100P_HUMAN	Increases Expression	[61]
Ribonucleoside-diphosphate reductase subunit M2 (RRM2)	OTOB6J6R	RIR2_HUMAN	Increases Expression	[61]
Low affinity immunoglobulin gamma Fc region receptor II-c (FCGR2C)	OTNLMNYB	FCG2C_HUMAN	Increases Expression	[61]
G protein-coupled receptor kinase 5 (GRK5)	OTJK79EK	GRK5_HUMAN	Increases Expression	[61]
RNA-binding protein 34 (RBM34)	OTX3LUGI	RBM34_HUMAN	Decreases Expression	[61]
Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1)	OT6E2OW6	ENTP1_HUMAN	Increases Expression	[61]
Tumor necrosis factor ligand superfamily member 10 (TNFSF10)	OT4PXBTA	TNF10_HUMAN	Increases Expression	[61]
Breast cancer type 2 susceptibility protein (BRCA2)	OTF1XSV1	BRCA2_HUMAN	Increases Expression	[61]
Geranylgeranyl transferase type-2 subunit beta (RABGGTB)	OTZ25I2W	PGTB2_HUMAN	Decreases Expression	[61]
UV excision repair protein RAD23 homolog A (RAD23A)	OTBPAWHX	RD23A_HUMAN	Decreases Expression	[61]
Ras-related protein Rab-5B (RAB5B)	OT06PN42	RAB5B_HUMAN	Increases Expression	[61]
C-X-C chemokine receptor type 4 (CXCR4)	OTUFSBX2	CXCR4_HUMAN	Increases Expression	[61]
Lysozyme C (LYZ)	OTD7H0G6	LYSC_HUMAN	Increases Expression	[61]
Histone H4 (H4C1)	OTB71W46	H4_HUMAN	Decreases Expression	[61]
DNA repair protein RAD51 homolog 1 (RAD51)	OTNVWGC1	RAD51_HUMAN	Increases Expression	[61]
Dual specificity protein phosphatase 4 (DUSP4)	OT6WAO12	DUS4_HUMAN	Decreases Expression	[61]
Src-like-adapter (SLA)	OTV17DY2	SLAP1_HUMAN	Increases Expression	[61]
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 (ACAP1)	OTPFQ2QC	ACAP1_HUMAN	Increases Expression	[61]
Cytohesin-1 (CYTH1)	OTYH9NRJ	CYH1_HUMAN	Increases Expression	[61]
C3a anaphylatoxin chemotactic receptor (C3AR1)	OT8J0TF8	C3AR_HUMAN	Increases Expression	[61]
Drebrin (DBN1)	OTZVKG8A	DREB_HUMAN	Decreases Expression	[61]
DALR anticodon-binding domain-containing protein 3 (DALRD3)	OTU79VIP	DALD3_HUMAN	Decreases Expression	[61]
Equilibrative nucleobase transporter 1 (SLC43A3)	OTR60ZLA	S43A3_HUMAN	Increases Expression	[61]
Glutathione S-transferase C-terminal domain-containing protein (GSTCD)	OTIIINMT	GSTCD_HUMAN	Increases Expression	[61]
DENN domain-containing protein 1A (DENND1A)	OTONDAA0	DEN1A_HUMAN	Increases Expression	[61]
Serine protease FAM111A (FAM111A)	OTVLARLG	F111A_HUMAN	Increases Expression	[61]
Proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2)	OTG6F93V	PPIP2_HUMAN	Decreases Expression	[61]
Partitioning defective 6 homolog alpha (PARD6A)	OTWLV3X1	PAR6A_HUMAN	Decreases Expression	[61]
Mediator of RNA polymerase II transcription subunit 9 (MED9)	OT59OKEJ	MED9_HUMAN	Decreases Expression	[61]
Phospholipid-transporting ATPase VD (ATP10D)	OT3JPE4H	AT10D_HUMAN	Increases Expression	[61]
Bridging integrator 2 (BIN2)	OT4S45WJ	BIN2_HUMAN	Increases Expression	[61]
DNA dC->dU-editing enzyme APOBEC-3B (APOBEC3B)	OTHLNI51	ABC3B_HUMAN	Increases Expression	[61]
Protein PRRC2C (PRRC2C)	OTBX3MXM	PRC2C_HUMAN	Decreases Expression	[61]
Odontogenic ameloblast-associated protein (ODAM)	OTT666SJ	ODAM_HUMAN	Decreases Expression	[62]
Pleckstrin homology domain-containing family G member 3 (PLEKHG3)	OTF6I8RV	PKHG3_HUMAN	Decreases Expression	[62]
Aldo-keto reductase family 1 member B15 (AKR1B15)	OTUEXSWH	AK1BF_HUMAN	Decreases Expression	[62]
Alternative prion protein (PRNP)	OTE85L1Q	APRIO_HUMAN	Decreases Expression	[62]
Matrilin-2 (MATN2)	OTVDR68G	MATN2_HUMAN	Decreases Expression	[62]
Homeobox protein Meis1 (MEIS1)	OTH9DKAD	MEIS1_HUMAN	Increases Expression	[62]
Gamma-aminobutyric acid receptor subunit pi (GABRP)	OTGKA8WS	GBRP_HUMAN	Increases Expression	[62]
Podocalyxin (PODXL)	OTPNQXF3	PODXL_HUMAN	Decreases Expression	[62]
Sarcolipin (SLN)	OTERIU75	SARCO_HUMAN	Decreases Expression	[62]
Nuclear factor 1 B-type (NFIB)	OTX94PD0	NFIB_HUMAN	Increases Expression	[62]
Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF1)	OTFK8KDP	NHRF1_HUMAN	Decreases Expression	[62]
Heparan sulfate glucosamine 3-O-sulfotransferase 1 (HS3ST1)	OT5DVN9P	HS3S1_HUMAN	Decreases Expression	[62]
Tetraspanin-4 (TSPAN4)	OTKFK57F	TSN4_HUMAN	Decreases Expression	[62]
Regulator of G-protein signaling 13 (RGS13)	OTPAMQ18	RGS13_HUMAN	Decreases Expression	[62]
Surfeit locus protein 4 (SURF4)	OTCSXJ9C	SURF4_HUMAN	Decreases Expression	[62]
Monocarboxylate transporter 4 (SLC16A3)	OTDIXEXY	MOT4_HUMAN	Decreases Expression	[62]
Prolyl 4-hydroxylase subunit alpha-2 (P4HA2)	OTP45YKX	P4HA2_HUMAN	Decreases Expression	[62]
Glycogenin-2 (GYG2)	OTAJ7YEW	GLYG2_HUMAN	Decreases Expression	[62]
Fatty acid-binding protein, brain (FABP7)	OTRE2H4G	FABP7_HUMAN	Increases Expression	[62]
Leucine-rich repeat transmembrane protein FLRT2 (FLRT2)	OTGD8TID	FLRT2_HUMAN	Decreases Expression	[62]
SLIT-ROBO Rho GTPase-activating protein 3 (SRGAP3)	OT9ZS72C	SRGP3_HUMAN	Increases Expression	[62]
Homeobox protein Hox-A2 (HOXA2)	OT6G6ZIK	HXA2_HUMAN	Increases Expression	[62]
Mothers against decapentaplegic homolog 6 (SMAD6)	OTUZZWUD	SMAD6_HUMAN	Decreases Expression	[62]
Carbonic anhydrase 12 (CA12)	OT6WNFU8	CAH12_HUMAN	Decreases Expression	[62]
Zinc finger protein SNAI2 (SNAI2)	OT7Y8EJ2	SNAI2_HUMAN	Decreases Expression	[62]
Transcription factor 21 (TCF21)	OT393IMA	TCF21_HUMAN	Decreases Expression	[62]
ER lumen protein-retaining receptor 3 (KDELR3)	OTW8C1V0	ERD23_HUMAN	Decreases Expression	[62]
Adhesion G protein-coupled receptor B3 (ADGRB3)	OT1EWGRW	AGRB3_HUMAN	Increases Expression	[62]
Protocadherin-7 (PCDH7)	OTP091X8	PCDH7_HUMAN	Decreases Expression	[62]
Suppression of tumorigenicity 18 protein (ST18)	OTPRIMTA	ST18_HUMAN	Increases Expression	[62]
TBC1 domain family member 4 (TBC1D4)	OTK66C40	TBCD4_HUMAN	Decreases Expression	[62]
Protein-tyrosine sulfotransferase 1 (TPST1)	OTDPQKEA	TPST1_HUMAN	Decreases Expression	[62]
Clathrin coat assembly protein AP180 (SNAP91)	OTE3EXWZ	AP180_HUMAN	Increases Expression	[62]
Kelch-like protein 41 (KLHL41)	OTLABE56	KLH41_HUMAN	Decreases Expression	[62]
Perilipin-3 (PLIN3)	OT9ZA7MR	PLIN3_HUMAN	Decreases Expression	[62]
P antigen family member 4 (PAGE4)	OT2VLWT0	PAGE4_HUMAN	Decreases Expression	[62]
Receptor activity-modifying protein 1 (RAMP1)	OT7UT2XB	RAMP1_HUMAN	Decreases Expression	[62]
Phosphatase and actin regulator 2 (PHACTR2)	OTWMX2A8	PHAR2_HUMAN	Decreases Expression	[62]
Leucine-rich repeat neuronal protein 2 (LRRN2)	OTGP2DCY	LRRN2_HUMAN	Decreases Expression	[62]
Cartilage-associated protein (CRTAP)	OT53H5U6	CRTAP_HUMAN	Decreases Expression	[62]
Breast cancer anti-estrogen resistance protein 3 (BCAR3)	OTPJ17M8	BCAR3_HUMAN	Decreases Expression	[62]
Matrix metalloproteinase-23 (MMP23B)	OT2OR6TS	MMP23_HUMAN	Decreases Expression	[62]
Regulator of G-protein signaling 20 (RGS20)	OT6CGYHW	RGS20_HUMAN	Increases Expression	[62]
Lymphocyte antigen 6H (LY6H)	OTTFGUD2	LY6H_HUMAN	Decreases Expression	[62]
Slit homolog 2 protein (SLIT2)	OTLS2RJ4	SLIT2_HUMAN	Decreases Expression	[62]
Sorbin and SH3 domain-containing protein 2 (SORBS2)	OTJSX44Y	SRBS2_HUMAN	Increases Expression	[62]
Glutaminase kidney isoform, mitochondrial (GLS)	OTGOZG2M	GLSK_HUMAN	Decreases Expression	[62]
SLIT and NTRK-like protein 3 (SLITRK3)	OT018P93	SLIK3_HUMAN	Decreases Expression	[62]
Myelin protein zero-like protein 1 (MPZL1)	OTJSUUHR	MPZL1_HUMAN	Decreases Expression	[62]
BAG family molecular chaperone regulator 3 (BAG3)	OTVXYUDQ	BAG3_HUMAN	Decreases Expression	[62]
EGF-containing fibulin-like extracellular matrix protein 2 (EFEMP2)	OT0I2B4J	FBLN4_HUMAN	Decreases Expression	[62]
Heart- and neural crest derivatives-expressed protein 1 (HAND1)	OTN4IPVV	HAND1_HUMAN	Decreases Expression	[62]
G1/S-specific cyclin-E2 (CCNE2)	OTBBUKQQ	CCNE2_HUMAN	Increases Expression	[62]
Cytochrome b5 (CYB5A)	OT6SN4RM	CYB5_HUMAN	Decreases Expression	[62]
Tissue-type plasminogen activator (PLAT)	OTQPDNAB	TPA_HUMAN	Decreases Expression	[62]
Serine protease inhibitor Kazal-type 1 (SPINK1)	OTSUVAL2	ISK1_HUMAN	Increases Expression	[62]
Metalloproteinase inhibitor 1 (TIMP1)	OTOXC51H	TIMP1_HUMAN	Decreases Expression	[62]
Pro-neuropeptide Y (NPY)	OT4ICV3P	NPY_HUMAN	Decreases Expression	[62]
Collagen alpha-1(I) chain (COL1A1)	OTI31178	CO1A1_HUMAN	Decreases Expression	[62]
Collagen alpha-1(III) chain (COL3A1)	OTT1EMLM	CO3A1_HUMAN	Decreases Expression	[62]
Alpha-crystallin B chain (CRYAB)	OTY4JGYU	CRYAB_HUMAN	Decreases Expression	[62]
Metallothionein-2 (MT2A)	OTHOACHD	MT2_HUMAN	Decreases Expression	[62]
Metallothionein-1A (MT1A)	OTKBH52X	MT1A_HUMAN	Decreases Expression	[62]
Metallothionein-1E (MT1E)	OTXJKU4Y	MT1E_HUMAN	Decreases Expression	[62]
Sodium/potassium-transporting ATPase subunit beta-1 (ATP1B1)	OTTO6ZP4	AT1B1_HUMAN	Decreases Expression	[62]
Keratin, type II cytoskeletal 8 (KRT8)	OTTM4X11	K2C8_HUMAN	Decreases Expression	[62]
Collagen alpha-2(V) chain (COL5A2)	OT5VOSQE	CO5A2_HUMAN	Decreases Expression	[62]
Tyrosine-protein kinase Fyn (FYN)	OTLSLVZS	FYN_HUMAN	Increases Expression	[62]
Tyrosine 3-monooxygenase (TH)	OT6ZORKP	TY3H_HUMAN	Decreases Expression	[62]
Annexin A2 (ANXA2)	OTFNS0CC	ANXA2_HUMAN	Decreases Expression	[62]
Calpain-1 catalytic subunit (CAPN1)	OTK6OQZR	CAN1_HUMAN	Decreases Expression	[62]
Decorin (DCN)	OTWLJL7K	PGS2_HUMAN	Decreases Expression	[62]
Procathepsin L (CTSL)	OTYTUW29	CATL1_HUMAN	Decreases Expression	[62]
Tyrosine-protein kinase Lyn (LYN)	OTP686K2	LYN_HUMAN	Decreases Expression	[62]
Thrombospondin-1 (THBS1)	OT0ECWK3	TSP1_HUMAN	Increases Expression	[62]
Collagen alpha-2(I) chain (COL1A2)	OTY7G382	CO1A2_HUMAN	Decreases Expression	[62]
Annexin A6 (ANXA6)	OT9KIQ0Y	ANXA6_HUMAN	Decreases Expression	[62]
Rho-related GTP-binding protein RhoC (RHOC)	OTOLE1FT	RHOC_HUMAN	Decreases Expression	[62]
Matrix Gla protein (MGP)	OTZWU3FU	MGP_HUMAN	Decreases Expression	[62]
Keratin, type I cytoskeletal 19 (KRT19)	OTDGDQ75	K1C19_HUMAN	Decreases Expression	[62]
SPARC (SPARC)	OTPN90H0	SPRC_HUMAN	Decreases Expression	[62]
Platelet-derived growth factor receptor beta (PDGFRB)	OTYSNK9Q	PGFRB_HUMAN	Decreases Expression	[62]
Homeobox protein Hox-C6 (HOXC6)	OTBCRAZV	HXC6_HUMAN	Decreases Expression	[62]
Pro-cathepsin H (CTSH)	OTLFL0DG	CATH_HUMAN	Decreases Expression	[62]
Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1)	OTXOQDSG	IFIT1_HUMAN	Decreases Expression	[62]
Thymosin beta-15A (TMSB15A)	OTSBWCES	TB15A_HUMAN	Increases Expression	[62]
Ras-related protein R-Ras (RRAS)	OTBBF28C	RRAS_HUMAN	Decreases Expression	[62]
Tissue factor pathway inhibitor (TFPI)	OTA0FX16	TFPI1_HUMAN	Decreases Expression	[62]
Growth hormone receptor (GHR)	OT8WUWMU	GHR_HUMAN	Decreases Expression	[62]
Hyaluronan and proteoglycan link protein 1 (HAPLN1)	OTXWR9TJ	HPLN1_HUMAN	Decreases Expression	[62]
Microtubule-associated protein 2 (MAP2)	OT6UYT3X	MTAP2_HUMAN	Increases Expression	[62]
Solute carrier family 2, facilitated glucose transporter member 1 (SLC2A1)	OTA675TJ	GTR1_HUMAN	Decreases Expression	[62]
Collagen alpha-2(VI) chain (COL6A2)	OTQC6PPO	CO6A2_HUMAN	Decreases Expression	[62]
Collagen alpha-3(VI) chain (COL6A3)	OTAS6R6I	CO6A3_HUMAN	Decreases Expression	[62]
Creatine kinase B-type (CKB)	OTUCKOTT	KCRB_HUMAN	Increases Expression	[62]
Bone morphogenetic protein 4 (BMP4)	OTPZMDFH	BMP4_HUMAN	Decreases Expression	[62]
Myosin light chain 4 (MYL4)	OTURFCSE	MYL4_HUMAN	Decreases Expression	[62]
Cytochrome b-245 light chain (CYBA)	OT16N9ZO	CY24A_HUMAN	Decreases Expression	[62]
Elongation factor 2 (EEF2)	OTZ7SZ39	EF2_HUMAN	Decreases Expression	[62]
Annexin A8 (ANXA8)	OTLSSQCY	ANXA8_HUMAN	Decreases Expression	[62]
Beta-enolase (ENO3)	OT3HYKYI	ENOB_HUMAN	Decreases Expression	[62]
Ezrin (EZR)	OTHBPF1Z	EZRI_HUMAN	Decreases Expression	[62]
N-chimaerin (CHN1)	OTM196M3	CHIN_HUMAN	Decreases Expression	[62]
CD44 antigen (CD44)	OT9TTJ41	CD44_HUMAN	Decreases Expression	[62]
Histone H1.2 (H1-2)	OT0AVI4M	H12_HUMAN	Decreases Expression	[62]
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 (GNB3)	OTA6HYBA	GBB3_HUMAN	Decreases Expression	[62]
Natriuretic peptides B (NPPB)	OTSN2IPY	ANFB_HUMAN	Increases Expression	[62]
Homeobox protein Hox-B8 (HOXB8)	OTKHOD17	HXB8_HUMAN	Decreases Expression	[62]
Homeobox protein Hox-B4 (HOXB4)	OTH1HRW5	HXB4_HUMAN	Decreases Expression	[62]
Homeobox protein Hox-B6 (HOXB6)	OT3TFQ0U	HXB6_HUMAN	Decreases Expression	[62]
Neuromodulin (GAP43)	OT2OTGGV	NEUM_HUMAN	Increases Expression	[62]
Insulin-like growth factor-binding protein 3 (IGFBP3)	OTIX63TX	IBP3_HUMAN	Decreases Expression	[62]
Integrin beta-5 (ITGB5)	OT21MF51	ITB5_HUMAN	Decreases Expression	[62]
Cyclic AMP-dependent transcription factor ATF-3 (ATF3)	OTC1UOHP	ATF3_HUMAN	Decreases Expression	[62]
Protachykinin-1 (TAC1)	OTM842YW	TKN1_HUMAN	Increases Expression	[62]
Homeobox protein Hox-A5 (HOXA5)	OTLWGPQD	HXA5_HUMAN	Increases Expression	[62]
Ephrin-A1 (EFNA1)	OTU2NUA2	EFNA1_HUMAN	Decreases Expression	[62]
Collagen alpha-1(IX) chain (COL9A1)	OTWBR27Y	CO9A1_HUMAN	Increases Expression	[62]
Collagen alpha-1(V) chain (COL5A1)	OT24078H	CO5A1_HUMAN	Decreases Expression	[62]
Cannabinoid receptor 1 (CNR1)	OTEALO6G	CNR1_HUMAN	Increases Expression	[62]
Tumor necrosis factor alpha-induced protein 3 (TNFAIP3)	OTVLI4DD	TNAP3_HUMAN	Decreases Expression	[62]
Midkine (MDK)	OTF24HKC	MK_HUMAN	Decreases Expression	[62]
Bone morphogenetic protein 5 (BMP5)	OTC0Y6E0	BMP5_HUMAN	Decreases Expression	[62]
Cadherin-3 (CDH3)	OTKNLQU7	CADH3_HUMAN	Decreases Expression	[62]
Calretinin (CALB2)	OTSNMCG9	CALB2_HUMAN	Decreases Expression	[62]
Fibulin-1 (FBLN1)	OT5MHHOP	FBLN1_HUMAN	Decreases Expression	[62]
Receptor-type tyrosine-protein phosphatase zeta (PTPRZ1)	OT2NRISU	PTPRZ_HUMAN	Increases Expression	[62]
Insulin-like growth factor-binding protein 5 (IGFBP5)	OTRE5V0C	IBP5_HUMAN	Decreases Expression	[62]
Paired box protein Pax-6 (PAX6)	OTOC9876	PAX6_HUMAN	Increases Expression	[62]
Protein S100-A4 (S100A4)	OTLRGFSQ	S10A4_HUMAN	Decreases Expression	[62]
Ciliary neurotrophic factor receptor subunit alpha (CNTFR)	OT3B1RGG	CNTFR_HUMAN	Increases Expression	[62]
Stomatin (STOM)	OTC8R6EH	STOM_HUMAN	Decreases Expression	[62]
Protein-lysine 6-oxidase (LOX)	OT1C2HIU	LYOX_HUMAN	Decreases Expression	[62]
Homeobox protein MSX-1 (MSX1)	OT5U41ZP	MSX1_HUMAN	Decreases Expression	[62]
Grancalcin (GCA)	OTAJ7ZHG	GRAN_HUMAN	Decreases Expression	[62]
Cellular retinoic acid-binding protein 1 (CRABP1)	OTISDG5X	RABP1_HUMAN	Increases Expression	[62]
Aquaporin-1 (AQP1)	OTX5MYX9	AQP1_HUMAN	Decreases Expression	[62]
G1/S-specific cyclin-D3 (CCND3)	OTNKPQ22	CCND3_HUMAN	Decreases Expression	[62]
Tyrosine-protein kinase receptor UFO (AXL)	OTKA2SUX	UFO_HUMAN	Decreases Expression	[62]
Translocator protein (TSPO)	OTSU7ESK	TSPO_HUMAN	Decreases Expression	[62]
Gastrin-releasing peptide receptor (GRPR)	OTBQGYJT	GRPR_HUMAN	Decreases Expression	[62]
Homeobox protein Hox-C8 (HOXC8)	OTJUYU8J	HXC8_HUMAN	Decreases Expression	[62]
Syndecan-4 (SDC4)	OTKUVUGZ	SDC4_HUMAN	Decreases Expression	[62]
Dimethylaniline monooxygenase 4 (FMO4)	OT5UYZL7	FMO4_HUMAN	Decreases Expression	[62]
Gastrin/cholecystokinin type B receptor (CCKBR)	OTQSNXOI	GASR_HUMAN	Decreases Expression	[62]
Serpin B6 (SERPINB6)	OT7G55IK	SPB6_HUMAN	Decreases Expression	[62]
Apelin receptor (APLNR)	OT8585HU	APJ_HUMAN	Decreases Expression	[62]
Copper-transporting ATPase 2 (ATP7B)	OTPWLNCO	ATP7B_HUMAN	Decreases Expression	[62]
Collagen alpha-1(XVIII) chain (COL18A1)	OTJFUH6O	COIA1_HUMAN	Decreases Expression	[62]
Melanocyte protein PMEL (PMEL)	OTCDDHHM	PMEL_HUMAN	Increases Expression	[62]
Peripherin (PRPH)	OT6VUH78	PERI_HUMAN	Decreases Expression	[62]
Transcription factor SOX-3 (SOX3)	OT1CRCOB	SOX3_HUMAN	Increases Expression	[62]
Glutamate receptor 2 (GRIA2)	OT5N1WB7	GRIA2_HUMAN	Increases Expression	[62]
Troponin T, cardiac muscle (TNNT2)	OT80NN7R	TNNT2_HUMAN	Decreases Expression	[62]
Peptidyl-prolyl cis-trans isomerase C (PPIC)	OTY5Q42N	PPIC_HUMAN	Decreases Expression	[62]
Leptin receptor (LEPR)	OT9H7G0C	LEPR_HUMAN	Decreases Expression	[62]
Neuromedin-U (NMU)	OTW9X7BQ	NMU_HUMAN	Increases Expression	[62]
Nestin (NES)	OTZ9PZ14	NEST_HUMAN	Increases Expression	[62]
Casein kinase I isoform delta (CSNK1D)	OTNF4S77	KC1D_HUMAN	Decreases Expression	[62]
CCAAT/enhancer-binding protein delta (CEBPD)	OTNBIPMY	CEBPD_HUMAN	Decreases Expression	[62]
Regulator of G-protein signaling 4 (RGS4)	OTG94HHL	RGS4_HUMAN	Decreases Expression	[62]
Cyclin-dependent kinase inhibitor 1C (CDKN1C)	OTASTJ3Q	CDN1C_HUMAN	Decreases Expression	[62]
Serpin B9 (SERPINB9)	OTJ811IF	SPB9_HUMAN	Decreases Expression	[62]
Serpin H1 (SERPINH1)	OTKGI7BS	SERPH_HUMAN	Decreases Expression	[62]
Ras association domain-containing protein 2 (RASSF2)	OT2JHDO4	RASF2_HUMAN	Increases Expression	[62]
Lipopolysaccharide-responsive and beige-like anchor protein (LRBA)	OTOUZN9G	LRBA_HUMAN	Decreases Expression	[62]
RNA-binding protein Nova-1 (NOVA1)	OT6A9KHY	NOVA1_HUMAN	Increases Expression	[62]
Neuronal membrane glycoprotein M6-a (GPM6A)	OT8G13EG	GPM6A_HUMAN	Increases Expression	[62]
Lumican (LUM)	OTSRC874	LUM_HUMAN	Decreases Expression	[62]
Heterogeneous nuclear ribonucleoprotein A3 (HNRNPA3)	OT4O4NFS	ROA3_HUMAN	Decreases Expression	[62]
Rho GDP-dissociation inhibitor 2 (ARHGDIB)	OT9PD6CS	GDIR2_HUMAN	Decreases Expression	[62]
Cationic amino acid transporter 2 (SLC7A2)	OTAMWBVM	CTR2_HUMAN	Decreases Expression	[62]
Atrophin-1 (ATN1)	OTNZFLKY	ATN1_HUMAN	Increases Expression	[62]
Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (PDE1A)	OTU7J3F7	PDE1A_HUMAN	Increases Expression	[62]
Hydroxymethylglutaryl-CoA synthase, mitochondrial (HMGCS2)	OTC3RUN9	HMCS2_HUMAN	Decreases Expression	[62]
Phospholipid transfer protein (PLTP)	OTVJJO5Z	PLTP_HUMAN	Decreases Expression	[62]
Microfibril-associated glycoprotein 4 (MFAP4)	OT5W64QY	MFAP4_HUMAN	Decreases Expression	[62]
Cadherin-11 (CDH11)	OTIZKPTF	CAD11_HUMAN	Decreases Expression	[62]
Claudin-15 (CLDN15)	OT9K0KI7	CLD15_HUMAN	Decreases Expression	[62]
Junctional adhesion molecule B (JAM2)	OTHVJJRJ	JAM2_HUMAN	Increases Expression	[62]
Myelin proteolipid protein (PLP1)	OT8CM9CX	MYPR_HUMAN	Increases Expression	[62]
Protein S100-A10 (S100A10)	OTI71243	S10AA_HUMAN	Decreases Expression	[62]
Heart- and neural crest derivatives-expressed protein 2 (HAND2)	OTCXYW4Y	HAND2_HUMAN	Decreases Expression	[62]
Neurocalcin-delta (NCALD)	OTJZ8UEL	NCALD_HUMAN	Increases Expression	[62]
cAMP-dependent protein kinase inhibitor alpha (PKIA)	OT8M5GVO	IPKA_HUMAN	Decreases Expression	[62]
Actin, alpha cardiac muscle 1 (ACTC1)	OTJU04B1	ACTC_HUMAN	Decreases Expression	[62]
Actin, alpha skeletal muscle (ACTA1)	OTOVGLPG	ACTS_HUMAN	Increases Expression	[62]
Pituitary homeobox 1 (PITX1)	OTA0UN4C	PITX1_HUMAN	Decreases Expression	[62]
Oxidized low-density lipoprotein receptor 1 (OLR1)	OTS44RIC	OLR1_HUMAN	Decreases Expression	[62]
Iroquois-class homeodomain protein IRX-5 (IRX5)	OT05J514	IRX5_HUMAN	Increases Expression	[62]
Reelin (RELN)	OTLKMW1O	RELN_HUMAN	Decreases Expression	[62]
Arginase-2, mitochondrial (ARG2)	OTCPI0E8	ARGI2_HUMAN	Decreases Expression	[62]
Metallothionein-1X (MT1X)	OT9AKFVS	MT1X_HUMAN	Decreases Expression	[62]
Matrix-remodeling-associated protein 7 (MXRA7)	OTVQLYIY	MXRA7_HUMAN	Decreases Expression	[62]
Disabled homolog 2 (DAB2)	OTRMQTMZ	DAB2_HUMAN	Decreases Expression	[62]
Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B (PDE1B)	OT9NPJCR	PDE1B_HUMAN	Increases Expression	[62]
Myosin regulatory light chain 2, atrial isoform (MYL7)	OT7ZNDP4	MLRA_HUMAN	Decreases Expression	[62]
Peripheral myelin protein 22 (PMP22)	OTXWYWCZ	PMP22_HUMAN	Decreases Expression	[62]
Flavin-containing monooxygenase 1 (FMO1)	OTTHSQKP	FMO1_HUMAN	Decreases Expression	[62]
ATP-dependent 6-phosphofructokinase, platelet type (PFKP)	OTFP7AA8	PFKAP_HUMAN	Decreases Expression	[62]
Zinc finger protein basonuclin-1 (BNC1)	OTGJ5WUF	BNC1_HUMAN	Decreases Expression	[62]
Transgelin (TAGLN)	OTAEZ0KP	TAGL_HUMAN	Increases Expression	[62]
Guanylate cyclase soluble subunit alpha-1 (GUCY1A1)	OTPTCBUN	GCYA1_HUMAN	Decreases Expression	[62]
Sterol 26-hydroxylase, mitochondrial (CYP27A1)	OT649C01	CP27A_HUMAN	Decreases Expression	[62]
Desmocollin-2 (DSC2)	OTODVH8K	DSC2_HUMAN	Decreases Expression	[62]
Angiopoietin-1 receptor (TEK)	OT78YN57	TIE2_HUMAN	Decreases Expression	[62]
Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (PLOD1)	OT3ZIANF	PLOD1_HUMAN	Decreases Expression	[62]
Transforming growth factor beta receptor type 3 (TGFBR3)	OTQOOUC4	TGBR3_HUMAN	Decreases Expression	[62]
Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R)	OTQF5ZAK	PTH1R_HUMAN	Decreases Expression	[62]
MBT domain-containing protein 1 (MBTD1)	OT2P6943	MBTD1_HUMAN	Increases Expression	[62]
3',5'-cyclic-AMP phosphodiesterase 4B (PDE4B)	OTOA8WU2	PDE4B_HUMAN	Increases Expression	[62]
Trefoil factor 3 (TFF3)	OTJJDRTU	TFF3_HUMAN	Increases Expression	[62]
Regulator of G-protein signaling 1 (RGS1)	OTGXJYMG	RGS1_HUMAN	Decreases Expression	[62]
Neuroblast differentiation-associated protein AHNAK (AHNAK)	OT6KH1WG	AHNK_HUMAN	Decreases Expression	[62]
Coiled-coil domain-containing protein 15 (CCDC15)	OT1NZX84	CCD15_HUMAN	Increases Expression	[62]
Transmembrane protein 62 (TMEM62)	OTJ4SPCM	TMM62_HUMAN	Increases Expression	[62]
Bone marrow stromal antigen 2 (BST2)	OTU4LCJV	BST2_HUMAN	Decreases Expression	[62]
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (ST3GAL1)	OTFCO8QX	SIA4A_HUMAN	Decreases Expression	[62]
Tyrosine-protein kinase Mer (MERTK)	OTWBRAJ6	MERTK_HUMAN	Decreases Expression	[62]
Transmembrane emp24 domain-containing protein 1 (TMED1)	OTWSH0J8	TMED1_HUMAN	Decreases Expression	[62]
Filamin-C (FLNC)	OT3F8J6Y	FLNC_HUMAN	Decreases Expression	[62]
Transforming growth factor beta activator LRRC32 (LRRC32)	OTG7EDZL	LRC32_HUMAN	Decreases Expression	[62]
Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (PIGH)	OTMCFF0K	PIGH_HUMAN	Decreases Expression	[62]
Desmocollin-3 (DSC3)	OTYG47F8	DSC3_HUMAN	Decreases Expression	[62]
Eukaryotic translation initiation factor 4H (EIF4H)	OTGZI072	IF4H_HUMAN	Decreases Expression	[62]
Periostin (POSTN)	OTWP62UA	POSTN_HUMAN	Decreases Expression	[62]
Phosphoglucomutase-like protein 5 (PGM5)	OTEAS7OC	PGM5_HUMAN	Decreases Expression	[62]
Nicotinate-nucleotide pyrophosphorylase (QPRT)	OT6SKKLL	NADC_HUMAN	Decreases Expression	[62]
Leucine-rich repeat-containing protein 41 (LRRC41)	OT4YSBV5	LRC41_HUMAN	Decreases Expression	[62]
Delta(24)-sterol reductase (DHCR24)	OTP301JW	DHC24_HUMAN	Decreases Expression	[62]
Probable G-protein coupled receptor 19 (GPR19)	OTR7MUS5	GPR19_HUMAN	Increases Expression	[62]
Alpha-internexin (INA)	OT1D33T4	AINX_HUMAN	Increases Expression	[62]
Kynureninase (KYNU)	OTINL2RE	KYNU_HUMAN	Decreases Expression	[62]
Thiosulfate sulfurtransferase (TST)	OTZ4F5LK	THTR_HUMAN	Decreases Expression	[62]
Reticulon-1 (RTN1)	OTCX1SMK	RTN1_HUMAN	Increases Expression	[62]
Discoidin domain-containing receptor 2 (DDR2)	OT9IHOGZ	DDR2_HUMAN	Decreases Expression	[62]
Rho GTPase-activating protein 44 (ARHGAP44)	OTHJUCO1	RHG44_HUMAN	Decreases Expression	[62]
Sodium-coupled monocarboxylate transporter 2 (SLC5A12)	OTKY9NAL	SC5AC_HUMAN	Decreases Expression	[62]
Keratin, type I cytoskeletal 24 (KRT24)	OTR7MT1E	K1C24_HUMAN	Decreases Expression	[62]
Electroneutral sodium bicarbonate exchanger 1 (SLC4A8)	OTKJ0X6Q	S4A8_HUMAN	Decreases Expression	[62]
HLA class II histocompatibility antigen, DR beta 5 chain (HLA-DRB5)	OTUX5TWM	DRB5_HUMAN	Decreases Expression	[62]
Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (MINDY4)	OTBZ2SZB	MINY4_HUMAN	Decreases Expression	[62]
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1 (PLCH1)	OT6Z1L2E	PLCH1_HUMAN	Increases Expression	[62]
Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (SVEP1)	OTOBICRD	SVEP1_HUMAN	Decreases Expression	[62]
PDZ and LIM domain protein 3 (PDLIM3)	OTVXQC81	PDLI3_HUMAN	Increases Expression	[62]
Protein LBH (LBH)	OT87AT1X	LBH_HUMAN	Decreases Expression	[62]
Cordon-bleu protein-like 1 (COBLL1)	OTQFN1TC	COBL1_HUMAN	Decreases Expression	[62]
Spindlin-4 (SPIN4)	OT09ZWHM	SPIN4_HUMAN	Decreases Expression	[62]
Trans-2,3-enoyl-CoA reductase-like (TECRL)	OTXLSNCP	TECRL_HUMAN	Decreases Expression	[62]
Placenta-specific protein 9 (PLAC9)	OTZHIJ44	PLAC9_HUMAN	Decreases Expression	[62]
Collectin-12 (COLEC12)	OTIQTK9G	COL12_HUMAN	Decreases Expression	[62]
CUGBP Elav-like family member 3 (CELF3)	OTTP45WK	CELF3_HUMAN	Increases Expression	[62]
KN motif and ankyrin repeat domain-containing protein 4 (KANK4)	OT5WC0Q8	KANK4_HUMAN	Decreases Expression	[62]
Transcription factor HES-5 (HES5)	OTW7JEHV	HES5_HUMAN	Increases Expression	[62]
Collagen alpha-1(XIII) chain (COL13A1)	OTM9IM6J	CODA1_HUMAN	Decreases Expression	[62]
Terminal nucleotidyltransferase 5C (TENT5C)	OTOWVQ4O	TET5C_HUMAN	Decreases Expression	[62]
FYN-binding protein 2 (FYB2)	OTA3NG8M	FYB2_HUMAN	Decreases Expression	[62]
F-actin-uncapping protein LRRC16A (CARMIL1)	OT1A5IX5	CARL1_HUMAN	Decreases Expression	[62]
Pikachurin (EGFLAM)	OTACZZJ0	EGFLA_HUMAN	Decreases Expression	[62]
Carboxypeptidase Z (CPZ)	OT5HUR28	CBPZ_HUMAN	Decreases Expression	[62]
NADH-cytochrome b5 reductase 2 (CYB5R2)	OTTLM7XN	NB5R2_HUMAN	Decreases Expression	[62]
Repulsive guidance molecule B (RGMB)	OT2DROYU	RGMB_HUMAN	Increases Expression	[62]
Caveolae-associated protein 1 (CAVIN1)	OTFO915U	CAVN1_HUMAN	Decreases Expression	[62]
Cdc42 effector protein 5 (CDC42EP5)	OTQQDUCD	BORG3_HUMAN	Decreases Expression	[62]
Cytochrome b5 domain-containing protein 1 (CYB5D1)	OTSZWTPT	CB5D1_HUMAN	Decreases Expression	[62]
Transmembrane protein 88 (TMEM88)	OTA96YEL	TMM88_HUMAN	Decreases Expression	[62]
Protein cornichon homolog 2 (CNIH2)	OTT2ECCW	CNIH2_HUMAN	Increases Expression	[62]
Prostate androgen-regulated mucin-like protein 1 (PARM1)	OTDNK7EX	PARM1_HUMAN	Decreases Expression	[62]
Inactive serine protease PAMR1 (PAMR1)	OT83ZH5U	PAMR1_HUMAN	Decreases Expression	[62]
R-spondin-2 (RSPO2)	OT3HHXU0	RSPO2_HUMAN	Decreases Expression	[62]
Zinc finger protein basonuclin-2 (BNC2)	OTU22H9Z	BNC2_HUMAN	Decreases Expression	[62]
Staphylococcal nuclease domain-containing protein 1 (SND1)	OTT734JN	SND1_HUMAN	Decreases Expression	[62]
Monocarboxylate transporter 9 (SLC16A9)	OTVCLKQQ	MOT9_HUMAN	Increases Expression	[62]
Centriolin (CNTRL)	OTQI3VBA	CNTRL_HUMAN	Increases Expression	[62]
Calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1)	OTKCR5XL	CK2N1_HUMAN	Increases Expression	[62]
Schlafen family member 11 (SLFN11)	OTJWFPMY	SLN11_HUMAN	Increases Expression	[62]
Polypeptide N-acetylgalactosaminyltransferase 10 (GALNT10)	OTZ6FDOL	GLT10_HUMAN	Decreases Expression	[62]
Alpha-protein kinase 2 (ALPK2)	OTWZZDQ9	ALPK2_HUMAN	Decreases Expression	[62]
E3 ubiquitin-protein ligase MARCHF3 (MARCHF3)	OT89V4N5	MARH3_HUMAN	Decreases Expression	[62]
Transmembrane protein 200A (TMEM200A)	OTVJZIOR	T200A_HUMAN	Decreases Expression	[62]
Podoplanin (PDPN)	OTBUV19I	PDPN_HUMAN	Decreases Expression	[62]
Rhophilin-2 (RHPN2)	OTTYWMF6	RHPN2_HUMAN	Decreases Expression	[62]
Epidermal growth factor-like protein 6 (EGFL6)	OT331X59	EGFL6_HUMAN	Decreases Expression	[62]
5'-3' exonuclease PLD3 (PLD3)	OTL07SP2	PLD3_HUMAN	Decreases Expression	[62]
Neuron navigator 2 (NAV2)	OTGAOL01	NAV2_HUMAN	Decreases Expression	[62]
Somatomedin-B and thrombospondin type-1 domain-containing protein (SBSPON)	OTBHAW5K	SBSPO_HUMAN	Decreases Expression	[62]
N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (GCNT2)	OTRUIMC4	GNT2A_HUMAN	Decreases Expression	[62]
Sperm-associated antigen 16 protein (SPAG16)	OTIFUPYD	SPG16_HUMAN	Increases Expression	[62]
Cytochrome P450 4X1 (CYP4X1)	OTMTEUNE	CP4X1_HUMAN	Decreases Expression	[62]
Inactive serine protease 35 (PRSS35)	OT09H6WH	PRS35_HUMAN	Decreases Expression	[62]
Secreted frizzled-related protein 1 (SFRP1)	OT0U9G41	SFRP1_HUMAN	Increases Expression	[62]
Reprimo-like protein (RPRML)	OTPOESFN	RPRML_HUMAN	Increases Expression	[62]
Actin filament-associated protein 1-like 2 (AFAP1L2)	OTJBI0VN	AF1L2_HUMAN	Decreases Expression	[62]
Protocadherin-20 (PCDH20)	OTFSNRXK	PCD20_HUMAN	Decreases Expression	[62]
Fibrous sheath-interacting protein 1 (FSIP1)	OTYLL6GM	FSIP1_HUMAN	Increases Expression	[62]
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (ST6GALNAC3)	OTLAQ14Q	SIA7C_HUMAN	Decreases Expression	[62]
Trinucleotide repeat-containing gene 6A protein (TNRC6A)	OT493IOM	TNR6A_HUMAN	Increases Expression	[62]
Coiled-coil domain-containing protein 112 (CCDC112)	OT3OEYG6	CC112_HUMAN	Increases Expression	[62]
Class E basic helix-loop-helix protein 22 (BHLHE22)	OTZUQY5L	BHE22_HUMAN	Increases Expression	[62]
Secretory carrier-associated membrane protein 5 (SCAMP5)	OT9MXA2J	SCAM5_HUMAN	Increases Expression	[62]
Protein odd-skipped-related 1 (OSR1)	OTB19LEQ	OSR1_HUMAN	Decreases Expression	[62]
DEP domain-containing mTOR-interacting protein (DEPTOR)	OTCBP1BT	DPTOR_HUMAN	Decreases Expression	[62]
Protein MGARP (MGARP)	OTL90XO8	HUMMR_HUMAN	Decreases Expression	[62]
Mucolipin-3 (MCOLN3)	OTCRPRVS	MCLN3_HUMAN	Decreases Expression	[62]
Breast carcinoma-amplified sequence 4 (BCAS4)	OT596N5E	BCAS4_HUMAN	Decreases Expression	[62]
E3 ubiquitin-protein ligase SH3RF2 (SH3RF2)	OT2IVOK4	SH3R2_HUMAN	Decreases Expression	[62]
Docking protein 4 (DOK4)	OTUEWLG8	DOK4_HUMAN	Decreases Expression	[62]
Probable phospholipid-transporting ATPase IM (ATP8B4)	OT48TSYO	AT8B4_HUMAN	Decreases Expression	[62]
Cell migration-inducing and hyaluronan-binding protein (CEMIP)	OTK80FYN	CEMIP_HUMAN	Decreases Expression	[62]
Leucine-rich repeat neuronal protein 4 (LRRN4)	OTC2T1MP	LRRN4_HUMAN	Decreases Expression	[62]
Selenoprotein M (SELENOM)	OTJ7PORS	SELM_HUMAN	Decreases Expression	[62]
Atlastin-1 (ATL1)	OTR2788Y	ATLA1_HUMAN	Increases Expression	[62]
E3 ubiquitin-protein ligase MYLIP (MYLIP)	OTL0PFGV	MYLIP_HUMAN	Decreases Expression	[62]
Cyclic GMP-AMP phosphodiesterase SMPDL3A (SMPDL3A)	OTQDYH8E	ASM3A_HUMAN	Decreases Expression	[62]
SEC14-like protein 1 (SEC14L1)	OTA75FET	S14L1_HUMAN	Decreases Expression	[62]
Protein NDRG1 (NDRG1)	OTVO66BO	NDRG1_HUMAN	Decreases Expression	[62]
Ankyrin repeat and SAM domain-containing protein 1A (ANKS1A)	OTYZP3MP	ANS1A_HUMAN	Decreases Expression	[62]
Serine protease HTRA1 (HTRA1)	OTR8ACBF	HTRA1_HUMAN	Decreases Expression	[62]
Secreted frizzled-related protein 3 (FRZB)	OTTO3DPY	SFRP3_HUMAN	Decreases Expression	[62]
Hyaluronan synthase 2 (HAS2)	OTTD3PAL	HYAS2_HUMAN	Decreases Expression	[62]
Proprotein convertase subtilisin/kexin type 5 (PCSK5)	OTP0RJ4Y	PCSK5_HUMAN	Decreases Expression	[62]
Kallikrein-6 (KLK6)	OTIEA234	KLK6_HUMAN	Decreases Expression	[62]
Exostosin-2 (EXT2)	OT8IR5QN	EXT2_HUMAN	Decreases Expression	[62]
Ecto-ADP-ribosyltransferase 4 (ART4)	OTTV2J54	NAR4_HUMAN	Decreases Expression	[62]
Caveolae-associated protein 3 (CAVIN3)	OTOLBK79	CAVN3_HUMAN	Decreases Expression	[62]
Myeloid-derived growth factor (MYDGF)	OT9HRPL6	MYDGF_HUMAN	Decreases Expression	[62]
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (ST6GALNAC6)	OT3C3VWX	SIA7F_HUMAN	Decreases Expression	[62]
Coiled-coil domain-containing protein 102A (CCDC102A)	OTT7XHIP	C102A_HUMAN	Decreases Expression	[62]
Ras-related and estrogen-regulated growth inhibitor (RERG)	OTF6MMLV	RERG_HUMAN	Decreases Expression	[62]
Ras-related protein Rab-37 (RAB37)	OTRL8IUO	RAB37_HUMAN	Decreases Expression	[62]
Store-operated calcium entry-associated regulatory factor (SARAF)	OTH5JIFE	SARAF_HUMAN	Decreases Expression	[62]
BTB/POZ domain-containing protein KCTD12 (KCTD12)	OTPYKT4Z	KCD12_HUMAN	Decreases Expression	[62]
Multivesicular body subunit 12A (MVB12A)	OT3737K0	MB12A_HUMAN	Decreases Expression	[62]
E3 ubiquitin-protein ligase pellino homolog 1 (PELI1)	OTMLBCLC	PELI1_HUMAN	Increases Expression	[62]
Phytanoyl-CoA hydroxylase-interacting protein-like (PHYHIPL)	OT9EIUGH	PHIPL_HUMAN	Increases Expression	[62]
Multidrug and toxin extrusion protein 1 (SLC47A1)	OTZX0U5Q	S47A1_HUMAN	Decreases Expression	[62]
Vacuolar-sorting protein SNF8 (SNF8)	OTRQA2AI	SNF8_HUMAN	Decreases Expression	[62]
Secreted frizzled-related protein 2 (SFRP2)	OT8GZ0CA	SFRP2_HUMAN	Increases Expression	[62]
PC-esterase domain-containing protein 1B (PCED1B)	OT19CDAB	PED1B_HUMAN	Decreases Expression	[62]
Terminal nucleotidyltransferase 5A (TENT5A)	OTSYF511	TET5A_HUMAN	Decreases Expression	[62]
Leucine-rich repeats and immunoglobulin-like domains protein 1 (LRIG1)	OTY5HZN5	LRIG1_HUMAN	Increases Expression	[62]
Lysyl oxidase homolog 4 (LOXL4)	OT6XY2JL	LOXL4_HUMAN	Decreases Expression	[62]
Multiple epidermal growth factor-like domains protein 10 (MEGF10)	OTILSPJ6	MEG10_HUMAN	Increases Expression	[62]
N-terminal kinase-like protein (SCYL1)	OTQ0IN7P	SCYL1_HUMAN	Decreases Expression	[62]
Ecto-ADP-ribosyltransferase 5 (ART5)	OTEZUT8V	NAR5_HUMAN	Decreases Expression	[62]
Protein phosphatase 1M (PPM1M)	OTCPLZQ7	PPM1M_HUMAN	Decreases Expression	[62]
Roundabout homolog 3 (ROBO3)	OTPVG40S	ROBO3_HUMAN	Increases Expression	[62]
Prickle-like protein 1 (PRICKLE1)	OT9HHEM9	PRIC1_HUMAN	Decreases Expression	[62]
Leucine-rich repeat and fibronectin type-III domain-containing protein 5 (LRFN5)	OTK7QZ3B	LRFN5_HUMAN	Decreases Expression	[62]
Guanylate-binding protein 4 (GBP4)	OTSPNGKX	GBP4_HUMAN	Decreases Expression	[62]
Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (MAGI1)	OTMV4ASV	MAGI1_HUMAN	Increases Expression	[62]
Myeloid-associated differentiation marker (MYADM)	OTZTZI7P	MYADM_HUMAN	Decreases Expression	[62]
Protein Niban 2 (NIBAN2)	OTVDQSPI	NIBA2_HUMAN	Decreases Expression	[62]
Transcription factor 12 (TCF12)	OTZVONNU	HTF4_HUMAN	Increases Expression	[62]
Protein kinase C-binding protein NELL2 (NELL2)	OTS4MJZ7	NELL2_HUMAN	Increases Expression	[62]
G-protein coupled estrogen receptor 1 (GPER1)	OTUK0TDC	GPER1_HUMAN	Decreases Expression	[62]
Pituitary homeobox 2 (PITX2)	OTWMXAOY	PITX2_HUMAN	Decreases Expression	[62]
Plakophilin-2 (PKP2)	OTJOVF68	PKP2_HUMAN	Decreases Expression	[62]
Cbp/p300-interacting transactivator 2 (CITED2)	OT812TV7	CITE2_HUMAN	Decreases Expression	[62]
Ribosome quality control complex subunit TCF25 (TCF25)	OTTFHHU9	TCF25_HUMAN	Decreases Expression	[62]
Allograft inflammatory factor 1-like (AIF1L)	OTDEOB80	AIF1L_HUMAN	Increases Expression	[62]
SH3-containing GRB2-like protein 3-interacting protein 1 (SGIP1)	OTQW6R3Z	SGIP1_HUMAN	Increases Expression	[62]
Transcription elongation factor A protein-like 7 (TCEAL7)	OTNPDZCN	TCAL7_HUMAN	Increases Expression	[62]
Histone H2A.J (H2AJ)	OTVA4XTW	H2AJ_HUMAN	Decreases Expression	[62]
Ribonuclease P protein subunit p25 (RPP25)	OTEN6QN7	RPP25_HUMAN	Decreases Expression	[62]
EF-hand domain-containing protein D1 (EFHD1)	OTL5INE4	EFHD1_HUMAN	Decreases Expression	[62]
Arginine/serine-rich protein 1 (RSRP1)	OTOAZLCL	RSRP1_HUMAN	Decreases Expression	[62]
Transmembrane emp24 domain-containing protein 9 (TMED9)	OTYGAQS0	TMED9_HUMAN	Decreases Expression	[62]
Max dimerization protein 3 (MXD3)	OT4U88UP	MAD3_HUMAN	Increases Expression	[62]
Transcription factor GATA-5 (GATA5)	OTO81B63	GATA5_HUMAN	Decreases Expression	[62]
Oxysterol-binding protein-related protein 10 (OSBPL10)	OT0TFMBE	OSB10_HUMAN	Decreases Expression	[62]
Uncharacterized protein KIAA1671 (KIAA1671)	OTYGNSCG	K1671_HUMAN	Decreases Expression	[62]
Tripartite motif-containing protein 6 (TRIM6)	OTBSMX0B	TRIM6_HUMAN	Decreases Expression	[62]
Tripartite motif-containing protein 5 (TRIM5)	OTMZH7EJ	TRIM5_HUMAN	Decreases Expression	[62]
RNA exonuclease 4 (REXO4)	OT2NNFKZ	REXO4_HUMAN	Decreases Expression	[62]
Disintegrin and metalloproteinase domain-containing protein 19 (ADAM19)	OTH88TXU	ADA19_HUMAN	Decreases Expression	[62]
Cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2)	OTVSFHTL	CRLD2_HUMAN	Decreases Expression	[62]
Gamma-aminobutyric acid receptor-associated protein-like 1 (GABARAPL1)	OT4U7SBG	GBRL1_HUMAN	Decreases Expression	[62]
Small conductance calcium-activated potassium channel protein 2 (KCNN2)	OTQVTMK5	KCNN2_HUMAN	Decreases Expression	[62]
Thiamin pyrophosphokinase 1 (TPK1)	OTCHPUD0	TPK1_HUMAN	Decreases Expression	[62]
SPARC-related modular calcium-binding protein 2 (SMOC2)	OTK1EQ49	SMOC2_HUMAN	Decreases Expression	[62]
Leucine-rich repeat neuronal protein 3 (LRRN3)	OT7X0AA7	LRRN3_HUMAN	Increases Expression	[62]
RWD domain-containing protein 1 (RWDD1)	OTVEZWQG	RWDD1_HUMAN	Increases Expression	[62]
Calcium-binding protein 39-like (CAB39L)	OTQEBL0W	CB39L_HUMAN	Decreases Expression	[62]
Spondin-1 (SPON1)	OTC06MY4	SPON1_HUMAN	Decreases Expression	[62]
Anoctamin-8 (ANO8)	OT07SRRX	ANO8_HUMAN	Increases Expression	[62]
Synaptotagmin-like protein 2 (SYTL2)	OTUIOWKL	SYTL2_HUMAN	Increases Expression	[62]
Solute carrier family 40 member 1 (SLC40A1)	OT8RV2VY	S40A1_HUMAN	Decreases Expression	[62]
Zinc transporter ZIP2 (SLC39A2)	OTE0GI4W	S39A2_HUMAN	Decreases Expression	[62]
NADPH oxidase 4 (NOX4)	OTTYQ097	NOX4_HUMAN	Decreases Expression	[62]
Nuclear receptor-interacting protein 3 (NRIP3)	OTU15GMK	NRIP3_HUMAN	Decreases Expression	[62]
G-protein coupled receptor family C group 5 member C (GPRC5C)	OT45AJT3	GPC5C_HUMAN	Decreases Expression	[62]
PR domain zinc finger protein 8 (PRDM8)	OTRA3265	PRDM8_HUMAN	Increases Expression	[62]
Integral membrane protein 2C (ITM2C)	OTHVMXE3	ITM2C_HUMAN	Decreases Expression	[62]
Rho guanine nucleotide exchange factor 3 (ARHGEF3)	OTHGNC0A	ARHG3_HUMAN	Decreases Expression	[62]
Olfactomedin-like protein 3 (OLFML3)	OTDN45FN	OLFL3_HUMAN	Decreases Expression	[62]
Kinesin-like protein KIF15 (KIF15)	OTJRJEXL	KIF15_HUMAN	Increases Expression	[62]
Serine palmitoyltransferase 3 (SPTLC3)	OTZDX6PT	SPTC3_HUMAN	Decreases Expression	[62]
Transmembrane protein 45A (TMEM45A)	OT54KJG6	TM45A_HUMAN	Decreases Expression	[62]
Host cell factor C1 regulator 1 (HCFC1R1)	OTGDPS5C	HPIP_HUMAN	Decreases Expression	[62]
Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase (BPNT2)	OT65C86U	IMPA3_HUMAN	Decreases Expression	[62]
PH and SEC7 domain-containing protein 3 (PSD3)	OTTN9B9O	PSD3_HUMAN	Increases Expression	[62]
G-protein coupled receptor 83 (GPR83)	OT7A2FE8	GPR83_HUMAN	Decreases Expression	[62]
Podocalyxin-like protein 2 (PODXL2)	OTB3PUR8	PDXL2_HUMAN	Increases Expression	[62]
Ral guanine nucleotide dissociation stimulator-like 1 (RGL1)	OTY6ZHVA	RGL1_HUMAN	Decreases Expression	[62]
Myoferlin (MYOF)	OTRFC3IJ	MYOF_HUMAN	Decreases Expression	[62]
Low-density lipoprotein receptor-related protein 1B (LRP1B)	OT4YZG2N	LRP1B_HUMAN	Decreases Expression	[62]
LIM and cysteine-rich domains protein 1 (LMCD1)	OT3AWE8O	LMCD1_HUMAN	Decreases Expression	[62]
Protein PALS2 (PALS2)	OTV12NKE	PALS2_HUMAN	Decreases Expression	[62]
Spermatogenesis-associated protein 7 (SPATA7)	OT78G2IH	SPAT7_HUMAN	Increases Expression	[62]
Neurotrimin (NTM)	OTHF0UQU	NTRI_HUMAN	Decreases Expression	[62]
C-type lectin domain family 1 member B (CLEC1B)	OTO38TRG	CLC1B_HUMAN	Decreases Expression	[62]
Dynein axonemal heavy chain 2 (DNAH2)	OT7J5LDI	DYH2_HUMAN	Decreases Expression	[62]
Semaphorin-5B (SEMA5B)	OTUVSKK0	SEM5B_HUMAN	Increases Expression	[62]
Signal-induced proliferation-associated 1-like protein 2 (SIPA1L2)	OT8NJE5D	SI1L2_HUMAN	Decreases Expression	[62]
Protein dispatched homolog 3 (DISP3)	OTEW6RYT	DISP3_HUMAN	Increases Expression	[62]
A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAMTS9)	OTV3Q0DS	ATS9_HUMAN	Decreases Expression	[62]
Vesicular glutamate transporter 2 (SLC17A6)	OTP1MJGP	VGLU2_HUMAN	Increases Expression	[62]
Beta-1,4-galactosyltransferase 7 (B4GALT7)	OTG5WHRW	B4GT7_HUMAN	Decreases Expression	[62]
Tachykinin-3 (TAC3)	OTOJGM38	TKNK_HUMAN	Decreases Expression	[62]
A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1)	OTTLJH8W	ATS1_HUMAN	Decreases Expression	[62]
Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAIAP2L1)	OTZ71SK9	BI2L1_HUMAN	Decreases Expression	[62]
SERTA domain-containing protein 1 (SERTAD1)	OTBHKZQP	SRTD1_HUMAN	Decreases Expression	[62]
F-box only protein 2 (FBXO2)	OTF3677S	FBX2_HUMAN	Decreases Expression	[62]
Angiopoietin-related protein 2 (ANGPTL2)	OTB6JG41	ANGL2_HUMAN	Decreases Expression	[62]
Microtubule-associated tumor suppressor 1 (MTUS1)	OTBPALMU	MTUS1_HUMAN	Increases Expression	[62]
Y+L amino acid transporter 1 (SLC7A7)	OTYNABBR	YLAT1_HUMAN	Decreases Expression	[62]
Lysosomal thioesterase PPT2 (PPT2)	OTD5VJ9A	PPT2_HUMAN	Decreases Expression	[62]
Protein NDRG2 (NDRG2)	OT5L6KD7	NDRG2_HUMAN	Decreases Expression	[62]
LIM and calponin homology domains-containing protein 1 (LIMCH1)	OTYPC4XA	LIMC1_HUMAN	Increases Expression	[62]
Type 2 lactosamine alpha-2,3-sialyltransferase (ST3GAL6)	OTB17Q43	SIA10_HUMAN	Decreases Expression	[62]
Nuclease EXOG, mitochondrial (EXOG)	OTZAI8L7	EXOG_HUMAN	Decreases Expression	[62]
Netrin-G1 (NTNG1)	OTF48IID	NTNG1_HUMAN	Increases Expression	[62]
Protein SSUH2 homolog (SSUH2)	OTWUBDV0	SSUH2_HUMAN	Increases Expression	[62]
Transmembrane protein 98 (TMEM98)	OTKDUEED	TMM98_HUMAN	Decreases Expression	[62]
Plasmolipin (PLLP)	OTFGCB9U	PLLP_HUMAN	Decreases Expression	[62]
C2 domain-containing protein 2 (C2CD2)	OTL1K0OB	C2CD2_HUMAN	Decreases Expression	[62]
Talin-2 (TLN2)	OT10QQBC	TLN2_HUMAN	Decreases Expression	[62]
Protein mab-21-like 2 (MAB21L2)	OTZM5VMX	MB212_HUMAN	Decreases Expression	[62]
Transient receptor potential cation channel subfamily V member 2 (TRPV2)	OT0A9AVD	TRPV2_HUMAN	Decreases Expression	[62]
Transcription factor SOX-21 (SOX21)	OTNT50CC	SOX21_HUMAN	Increases Expression	[62]
LHFPL tetraspan subfamily member 6 protein (LHFPL6)	OTY6LHJY	LHPL6_HUMAN	Increases Expression	[62]
Stonin-1 (STON1)	OT2HPUAI	STON1_HUMAN	Decreases Expression	[62]
Transcription factor E2F8 (E2F8)	OTQKZGFP	E2F8_HUMAN	Increases Expression	[63]
Thymidine kinase 2, mitochondrial (TK2)	OTS1V4XB	KITM_HUMAN	Decreases Expression	[75]
Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B)	OTA1CPBV	TR10B_HUMAN	Increases Expression	[76]
Protein regulator of cytokinesis 1 (PRC1)	OTHD0XS0	PRC1_HUMAN	Decreases Expression	[31]
PRA1 family protein 3 (ARL6IP5)	OTYZ6BEQ	PRAF3_HUMAN	Increases Expression	[77]
Prothrombin (F2)	OTNFSM49	THRB_HUMAN	Affects Expression	[78]
Plasminogen (PLG)	OTWWIPPY	PLMN_HUMAN	Affects Localization	[79]
Prolactin (PRL)	OTWFQGX7	PRL_HUMAN	Increases Expression	[80]
Tumor necrosis factor (TNF)	OT4IE164	TNFA_HUMAN	Increases Expression	[81]
Thymidine kinase, cytosolic (TK1)	OTY5JFM1	KITH_HUMAN	Decreases Expression	[75]
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)	OTBPMIMW	G3P_HUMAN	Decreases Activity	[82]
Interleukin-6 (IL6)	OTUOSCCU	IL6_HUMAN	Increases Expression	[81]
Transcription factor Jun (JUN)	OTCYBO6X	JUN_HUMAN	Increases Expression	[83]
High mobility group protein B1 (HMGB1)	OT4B7CPF	HMGB1_HUMAN	Increases Secretion	[84]
Poly polymerase 1 (PARP1)	OT310QSG	PARP1_HUMAN	Increases Degradation	[85]
Apoptosis regulator Bcl-2 (BCL2)	OT9DVHC0	BCL2_HUMAN	Decreases Expression	[83]
Histone H2AX (H2AX)	OT18UX57	H2AX_HUMAN	Increases Phosphorylation	[82]
Growth arrest and DNA damage-inducible protein GADD45 alpha (GADD45A)	OTDRV63V	GA45A_HUMAN	Increases Expression	[63]
Tumor necrosis factor receptor superfamily member 6 (FAS)	OTP9XG86	TNR6_HUMAN	Increases Expression	[63]
Cyclin-dependent kinases regulatory subunit 2 (CKS2)	OTPTMHIV	CKS2_HUMAN	Decreases Expression	[31]
Cyclin-dependent kinase inhibitor 1 (CDKN1A)	OTQWHCZE	CDN1A_HUMAN	Increases Expression	[63]
Caspase-3 (CASP3)	OTIJRBE7	CASP3_HUMAN	Increases Activity	[86]
Importin subunit alpha-1 (KPNA2)	OTU7FOE6	IMA1_HUMAN	Decreases Expression	[31]
Sestrin-3 (SESN3)	OTJRY1Y5	SESN3_HUMAN	Decreases Expression	[63]
Beta-2-microglobulin (B2M)	OTDWN6NX	B2MG_HUMAN	Increases Expression	[87]
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 (PLCB2)	OTPAHDGO	PLCB2_HUMAN	Affects Localization	[88]
Transcription factor p65 (RELA)	OTUJP9CN	TF65_HUMAN	Decreases Activity	[89]
Apoptosis regulator BAX (BAX)	OTAW0V4V	BAX_HUMAN	Increases Expression	[90]
Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1)	OT2YYI1A	MCL1_HUMAN	Decreases Expression	[91]
Cyclin-dependent kinase 5 activator 1 (CDK5R1)	OTJELWK0	CD5R1_HUMAN	Increases Expression	[63]
Borealin (CDCA8)	OT17D55D	BOREA_HUMAN	Decreases Expression	[31]
Proline/serine-rich coiled-coil protein 1 (PSRC1)	OT7MDJMN	PSRC1_HUMAN	Decreases Expression	[31]
Protein aurora borealis (BORA)	OTV2ZPKP	BORA_HUMAN	Decreases Expression	[31]
Jouberin (AHI1)	OT8K2YWY	AHI1_HUMAN	Increases Expression	[92]
Transient receptor potential cation channel subfamily V member 1 (TRPV1)	OTHHDR03	TRPV1_HUMAN	Affects Localization	[93]
Tumor necrosis factor receptor superfamily member 19 (TNFRSF19)	OTTVT4MB	TNR19_HUMAN	Decreases Expression	[63]
Solute carrier family 12 member 6 (SLC12A6)	OT9CS413	S12A6_HUMAN	Decreases Expression	[63]
Lactosylceramide alpha-2,3-sialyltransferase (ST3GAL5)	OT27CCUF	SIAT9_HUMAN	Decreases Expression	[63]
Hairy/enhancer-of-split related with YRPW motif protein 1 (HEY1)	OTJQL0I3	HEY1_HUMAN	Decreases Expression	[63]
Interleukin-3 (IL3)	OT0CQ35N	IL3_HUMAN	Increases ADR	[94]
Kynurenine 3-monooxygenase (KMO)	OT3MRMM9	KMO_HUMAN	Increases Response To Substance	[95]
Stathmin-4 (STMN4)	OT7ZUKW6	STMN4_HUMAN	Increases Response To Substance	[95]
Histone-lysine N-methyltransferase 2A (KMT2A)	OT9GLJI6	KMT2A_HUMAN	Increases Response To Substance	[96]
Protein lyl-1 (LYL1)	OTCNOV1M	LYL1_HUMAN	Decreases Response To Substance	[97]
Metalloproteinase inhibitor 3 (TIMP3)	OTDGQAD1	TIMP3_HUMAN	Decreases Response To Substance	[98]
Tumor protein p53-inducible protein 11 (TP53I11)	OTFPDYZU	P5I11_HUMAN	Increases Response To Substance	[95]
Hepatocyte growth factor (HGF)	OTGHUA23	HGF_HUMAN	Increases ADR	[94]
Multidrug resistance-associated protein 1 (ABCC1)	OTGUN89S	MRP1_HUMAN	Affects Response To Substance	[99]
Cellular tumor antigen p53 (TP53)	OTIE1VH3	P53_HUMAN	Increases Response To Substance	[100]
14-3-3 protein sigma (SFN)	OTLJCZ1U	1433S_HUMAN	Decreases Response To Substance	[101]
Protein kinase C zeta type (PRKCZ)	OTN2FE42	KPCZ_HUMAN	Decreases Response To Substance	[52]
Calcitonin receptor (CALCR)	OTOVDJ7S	CALCR_HUMAN	Increases Response To Substance	[95]
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (PTEN)	OTOWDUNT	PTEN_HUMAN	Increases Response To Substance	[102]
Glutathione S-transferase Mu 1 (GSTM1)	OTSBF2MO	GSTM1_HUMAN	Affects Response To Substance	[13]
Methylenetetrahydrofolate reductase (MTHFR)	OTUBJSR7	MTHR_HUMAN	Affects Response To Substance	[98]
Deoxycytidine kinase (DCK)	OTW8HLZC	DCK_HUMAN	Decreases Response To Substance	[74]

Test Results of This Drug Combination in Other Disease Systems

Indication	DrugCom ID	Cell Line	Status	REF
Newly Diagnosed AML With FLT3 Activating Mutations	DCU9GCL	N. A.	Phase 2	[103]
Leukemia	DCH5YZL	N. A.	Phase 1	[104]

References

• [1] ClinicalTrials.gov (NCT00788892) Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
• [2] Daunorubicin FDA Label
• [3] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7063).
• [4] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [5] Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer. Eur J Cancer. 2004 Mar;40(4):536-42.
• [6] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4827).
• [7] Cytarabine FDA Label
• [8] Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment. Arch Toxicol. 2016 Nov;90(11):2763-2777.
• [9] Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor. Sci Rep. 2014 Sep 26;4:6437. doi: 10.1038/srep06437.
• [10] Cell-based and cytokine-directed chemical screen to identify potential anti-multiple myeloma agents. Leuk Res. 2010 Jul;34(7):917-24. doi: 10.1016/j.leukres.2009.12.002. Epub 2010 Feb 8.
• [11] Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity. Br J Clin Pharmacol. 2016 Sep;82(3):683-95. doi: 10.1111/bcp.13008. Epub 2016 Jun 30.
• [12] Mapping genes that contribute to daunorubicin-induced cytotoxicity. Cancer Res. 2007 Jun 1;67(11):5425-33. doi: 10.1158/0008-5472.CAN-06-4431.
• [13] Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood. 2005 Jun 15;105(12):4752-8. doi: 10.1182/blood-2004-11-4544. Epub 2005 Feb 15.
• [14] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
• [15] 31P NMR spectra of ethidium, quinacrine, and daunomycin complexes with poly(adenylic acid).poly(uridylic acid) RNA duplex and calf thymus DNA. Biochemistry. 1989 Apr 4;28(7):2804-12.
• [16] Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer. 2000 Aug;83(3):375-83.
• [17] Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.
• [18] Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem Biophys Res Commun. 2001 Jul 6;285(1):111-7.
• [19] Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res. 2002 Nov 1;62(21):6172-7.
• [20] The effect of new lipophilic chelators on the activities of cytosolic reductases and P450 cytochromes involved in the metabolism of anthracycline antibiotics: studies in vitro. Physiol Res. 2004;53(6):683-91.
• [21] Flavonoids as inhibitors of human carbonyl reductase 1. Chem Biol Interact. 2008 Jul 30;174(2):98-108.
• [22] Naturally occurring variants of human CBR3 alter anthracycline in vitro metabolism. J Pharmacol Exp Ther. 2010 Mar;332(3):755-63.
• [23] Lack of mechanism-based inactivation of rat hepatic microsomal cytochromes P450 by doxorubicin. Can J Physiol Pharmacol. 1999 Aug;77(8):589-97.
• [24] Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance. Neoplasia. 2009 Dec;11(12):1359-70. doi: 10.1593/neo.91314.
• [25] Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells. Int J Nanomedicine. 2010 Aug 9;5:437-44. doi: 10.2147/ijn.s10083.
• [26] Cloning and functional characterization of the multidrug resistance-associated protein (MRP1/ABCC1) from the cynomolgus monkey. Mol Cancer Ther. 2003 Mar;2(3):307-16.
• [27] Genetic variants contributing to daunorubicin-induced cytotoxicity. Cancer Res. 2008 May 1;68(9):3161-8. doi: 10.1158/0008-5472.CAN-07-6381.
• [28] A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. Nat Genet. 2015 Sep;47(9):1079-84. doi: 10.1038/ng.3374. Epub 2015 Aug 3.
• [29] High-throughput library screening identifies two novel NQO1 inducers in human lung cells. Am J Respir Cell Mol Biol. 2012 Mar;46(3):365-71.
• [30] Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis. Apoptosis. 2002 Dec;7(6):537-48. doi: 10.1023/a:1020647211557.
• [31] Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling. Mutat Res. 2007 Jun 1;619(1-2):16-29. doi: 10.1016/j.mrfmmm.2006.12.007. Epub 2007 Feb 8.
• [32] BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia. Blood Cancer J. 2013 Jul 19;3(7):e126. doi: 10.1038/bcj.2013.24.
• [33] Daunorubicin-induced variations in gene transcription: commitment to proliferation arrest, senescence and apoptosis. Biochem J. 2003 Jun 15;372(Pt 3):703-11. doi: 10.1042/BJ20021950.
• [34] Identification of the key pathway of oxazolinoanthracyclines mechanism of action in cells derived from human solid tumors. Toxicol Appl Pharmacol. 2016 Dec 15;313:159-169. doi: 10.1016/j.taap.2016.10.018. Epub 2016 Oct 22.
• [35] Discovery of selective glucocorticoid receptor modulators by multiplexed reporter screening. Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4929-34. doi: 10.1073/pnas.0812308106. Epub 2009 Mar 2.
• [36] Daunorubicin attenuates tumor necrosis factor-alpha-induced biosynthesis of plasminogen activator inhibitor-1 in human umbilical vein endothelial cells. Biochim Biophys Acta. 2001 Apr 23;1538(2-3):234-41. doi: 10.1016/s0167-4889(01)00073-8.
• [37] Role of endothelin-1 in the development of a special type of cardiomyopathy. Clin Sci (Lond). 2002 Aug;103 Suppl 48:272S-275S. doi: 10.1042/CS103S272S.
• [38] [Influence of arsenic trioxide and daunorubicin on the expression of annexin II and fibrinolytic activity in NB4 cells]. Zhonghua Xue Ye Xue Za Zhi. 2010 Dec;31(12):813-6.
• [39] CREB/Sp1-mediated MCL1 expression and NFB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells. Toxicol Appl Pharmacol. 2022 Jan 15;435:115847. doi: 10.1016/j.taap.2021.115847. Epub 2021 Dec 25.
• [40] Anthracyclines trigger apoptosis of both G0-G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells. Cancer Res. 2000 Apr 1;60(7):1901-7.
• [41] Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice. Int J Nanomedicine. 2009;4:73-8. doi: 10.2147/ijn.s5093. Epub 2009 Apr 1.
• [42] Pharmacologic reductions of total tau levels; implications for the role of microtubule dynamics in regulating tau expression. Mol Neurodegener. 2006 Jul 26;1:6. doi: 10.1186/1750-1326-1-6.
• [43] [Effects of all-trans retinoic acid, arsenic trioxide and daunorubicin on tissue factor expression in NB4 cells]. Zhonghua Xue Ye Xue Za Zhi. 1999 Sep;20(9):453-5.
• [44] Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity. Acta Haematol. 2000;104(4):158-63. doi: 10.1159/000046508.
• [45] Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin. Biochim Biophys Acta. 2009 Nov-Dec;1789(11-12):681-90. doi: 10.1016/j.bbagrm.2009.08.006. Epub 2009 Aug 19.
• [46] Antileukaemia effect of rapamycin alone or in combination with daunorubicin on Ph+ acute lymphoblastic leukaemia cell line. Hematol Oncol. 2012 Sep;30(3):123-30. doi: 10.1002/hon.1013. Epub 2011 Sep 4.
• [47] Regulation of phospholipase D activity and ceramide production in daunorubicin-induced apoptosis in A-431 cells. Biochim Biophys Acta. 2000 Nov 15;1488(3):219-32. doi: 10.1016/s1388-1981(00)00125-6.
• [48] Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2. Cancer Sci. 2008 Aug;99(8):1693-8. doi: 10.1111/j.1349-7006.2008.00867.x.
• [49] Resistance of bcr-abl-positive acute lymphoblastic leukemia to daunorubicin is not mediated by mdr1 gene expression. Am J Hematol. 2002 Nov;71(3):172-6. doi: 10.1002/ajh.10212.
• [50] Daunorubicin induces cell death via activation of apoptotic signalling pathway and inactivation of survival pathway in muscle-derived stem cells. Cell Biol Toxicol. 2012 Apr;28(2):103-14. doi: 10.1007/s10565-011-9210-x. Epub 2012 Jan 18.
• [51] Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100. Biochem Biophys Res Commun. 2001 Feb 16;281(1):109-14. doi: 10.1006/bbrc.2001.4324.
• [52] 4-benzimidazolyl-3-phenylbutanoic acids as novel PIF-pocket-targeting allosteric inhibitors of protein kinase PKC. J Med Chem. 2011 Oct 13;54(19):6714-23. doi: 10.1021/jm2005892. Epub 2011 Sep 14.
• [53] siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53. Leuk Res. 2009 Sep;33(9):1243-8. doi: 10.1016/j.leukres.2009.02.016. Epub 2009 Mar 18.
• [54] Cancer biomarker AKR1B10 and carbonyl metabolism. Chem Biol Interact. 2009 Mar 16;178(1-3):134-7. doi: 10.1016/j.cbi.2008.10.044. Epub 2008 Nov 5.
• [55] Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line. FEBS Lett. 2011 Jan 21;585(2):402-8. doi: 10.1016/j.febslet.2010.12.027. Epub 2010 Dec 25.
• [56] Niemann-Pick C1 protein facilitates the efflux of the anticancer drug daunorubicin from cells according to a novel vesicle-mediated pathway. J Pharmacol Exp Ther. 2006 Jan;316(1):242-7. doi: 10.1124/jpet.105.089482. Epub 2005 Sep 20.
• [57] Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem J. 1999 Oct 15;343 Pt 2(Pt 2):487-504.
• [58] Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile. Arch Toxicol. 2018 Sep;92(9):2845-2857.
• [59] Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro. Drug Metab Dispos. 2008 Jun;36(6):991-4. doi: 10.1124/dmd.108.020388. Epub 2008 Mar 5.
• [60] Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. Int J Cancer. 2009 Apr 1;124(7):1727-35. doi: 10.1002/ijc.24108.
• [61] The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia. 2009 Jun;23(6):1019-28.
• [62] Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
• [63] Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells. Arch Toxicol. 2021 May;95(5):1631-1645. doi: 10.1007/s00204-021-03014-2. Epub 2021 Mar 26.
• [64] Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res. 2000 May;6(5):1796-803.
• [65] Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2. Biochim Biophys Acta. 2014 Feb;1843(2):387-97. doi: 10.1016/j.bbamcr.2013.10.015. Epub 2013 Oct 31.
• [66] Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage. Mol Cancer Ther. 2009 Apr;8(4):864-72.
• [67] Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
• [68] OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues. Cancer Res. 2017 Apr 15;77(8):2102-2111.
• [69] FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia. Oncotarget. 2016 Aug 2;7(31):49786-49799.
• [70] Synthesis and characterization of a novel liver-targeted prodrug of cytosine-1-beta-D-arabinofuranoside monophosphate for the treatment of hepatocellular carcinoma. J Med Chem. 2006 Dec 28;49(26):7711-20.
• [71] Genetic factors influencing cytarabine therapy. Pharmacogenomics. 2009 Oct;10(10):1657-74.
• [72] Mycoplasma hyorhinis-encoded cytidine deaminase efficiently inactivates cytosine-based anticancer drugs. FEBS Open Bio. 2015 Aug 3;5:634-9.
• [73] [Relationship between the induction of MDR1, a multidrug resistance gene in tumor cells, and apoptosis]. Ontogenez. 2001 Jul-Aug;32(4):295-301.
• [74] Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells. Cancer Res. 2008 Apr 1;68(7):2349-57. doi: 10.1158/0008-5472.CAN-07-5528.
• [75] Arabinosylcytosine downregulates thymidine kinase and induces cross-resistance to zidovudine in T-lymphoid cells. Biochem Biophys Res Commun. 2003 Aug 1;307(3):564-8. doi: 10.1016/s0006-291x(03)01232-4.
• [76] [Combined effect of TNF-related apoptosis induced ligand and Ara-C in inducing apoptosis of HL-60 cells and its mechanism]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Jun;16(3):510-5.
• [77] JWA, a novel signaling molecule, involved in the induction of differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun. 2006 Mar 10;341(2):440-50. doi: 10.1016/j.bbrc.2005.12.197. Epub 2006 Jan 11.
• [78] The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces. Br J Haematol. 2003 Jan;120(2):315-24. doi: 10.1046/j.1365-2141.2003.03971.x.
• [79] Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator. Thromb Res. 2002 Apr 1;106(1):63-70. doi: 10.1016/s0049-3848(02)00075-0.
• [80] Prolactinemia in adolescent males surviving malignancies in childhood: impaired dating activity. J Adolesc Health. 1993 Nov;14(7):543-7. doi: 10.1016/1054-139x(93)90138-f.
• [81] Proinflammatory cytokines mediate the systemic inflammatory response associated with high-dose cytarabine treatment in children. Med Pediatr Oncol. 2001 Nov;37(5):459-64. doi: 10.1002/mpo.1230.
• [82] Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines. J Pharmacol Exp Ther. 2009 Oct;331(1):77-86. doi: 10.1124/jpet.109.155671. Epub 2009 Jul 23.
• [83] Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells. Blood. 1992 Dec 1;80(11):2883-90.
• [84] [Influence of HMGB1/MAPK/m-TOR signaling pathway on cell autophagy and chemotherapy resistance in K562 cells]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016 Oct 28;41(10):1016-1023. doi: 10.11817/j.issn.1672-7347.2016.10.002.
• [85] Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res. 1996 Oct 15;56(20):4743-8.
• [86] Ara-C induces apoptosis in monkey fibroblast cells. Toxicol In Vitro. 2003 Jun;17(3):367-73. doi: 10.1016/s0887-2333(03)00024-9.
• [87] Cytosine arabinoside induced acute interstitial nephritis in a patient treated for refractory anemia with excess of blasts in transformation. Nephron. 2000 Nov;86(3):356-7. doi: 10.1159/000045798.
• [88] Protein kinase CbetaII activation by 1-beta-D-arabinofuranosylcytosine is antagonistic to stimulation of apoptosis and Bcl-2alpha down-regulation. J Biol Chem. 1997 Sep 19;272(38):23481-4. doi: 10.1074/jbc.272.38.23481.
• [89] Mechanism of cytosine arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation. Oncogene. 2003 Jul 10;22(28):4356-69. doi: 10.1038/sj.onc.1206486.
• [90] Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment. Cell Death Differ. 1998 Jul;5(7):584-91. doi: 10.1038/sj.cdd.4400382.
• [91] The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells. Haematologica. 2006 Jul;91(7):912-9.
• [92] [Expression and function of Ahi-1 gene in Jurkat cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Apr;17(2):445-9.
• [93] Cytosine arabinoside affects the heat and capsaicin receptor TRPV1 localisation and sensitivity in human sensory neurons. J Neurooncol. 2008 Aug;89(1):1-7. doi: 10.1007/s11060-008-9585-6. Epub 2008 Apr 15.
• [94] ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
• [95] Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans. PLoS One. 2011;6(7):e21920. doi: 10.1371/journal.pone.0021920. Epub 2011 Jul 6.
• [96] In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. Leukemia. 2004 Mar;18(3):521-9. doi: 10.1038/sj.leu.2403253.
• [97] Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia. Leukemia. 2005 Nov;19(11):1941-7. doi: 10.1038/sj.leu.2403836.
• [98] DNA methylation and sensitivity to antimetabolites in cancer cell lines. Oncol Rep. 2008 Feb;19(2):407-12.
• [99] Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance. Hematology. 2007 Dec;12(6):511-7. doi: 10.1080/10245330701562535.
• [100] Chromosome breakage induced by the genotoxic agents mitomycin C and cytosine arabinoside is concentration and p53 dependent. Toxicol Sci. 2014 Jul;140(1):94-102. doi: 10.1093/toxsci/kfu058. Epub 2014 Mar 27.
• [101] Reversible epigenetic regulation of 14-3-3 expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1. Mol Pharmacol. 2014 Nov;86(5):561-9. doi: 10.1124/mol.114.092544. Epub 2014 Sep 4.
• [102] Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells. Leuk Lymphoma. 2012 Jul;53(7):1383-9. doi: 10.3109/10428194.2011.650695. Epub 2012 Jan 31.
• [103] ClinicalTrials.gov (NCT02283177) A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations
• [104] ClinicalTrials.gov (NCT00085709) S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML